BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Attems J, Jellinger KA. The overlap between vascular disease and Alzheimer's disease--lessons from pathology. BMC Med 2014;12:206. [PMID: 25385447 DOI: 10.1186/s12916-014-0206-2] [Cited by in Crossref: 327] [Cited by in F6Publishing: 342] [Article Influence: 40.9] [Reference Citation Analysis]
Number Citing Articles
1 Elman-shina K, Efrati S. Ischemia as a common trigger for Alzheimer’s disease. Front Aging Neurosci 2022;14:1012779. [DOI: 10.3389/fnagi.2022.1012779] [Reference Citation Analysis]
2 Kim SE, Kim HJ, Jang H, Weiner MW, DeCarli C, Na DL, Seo SW. Interaction between Alzheimer's Disease and Cerebral Small Vessel Disease: A Review Focused on Neuroimaging Markers. Int J Mol Sci 2022;23:10490. [PMID: 36142419 DOI: 10.3390/ijms231810490] [Reference Citation Analysis]
3 Toniolo S, Romoli M, Sen A. Epilepsy in Older Persons. Neurologic Clinics 2022. [DOI: 10.1016/j.ncl.2022.03.014] [Reference Citation Analysis]
4 Yu W, Li Y, Hu J, Wu J, Huang Y. A Study on the Pathogenesis of Vascular Cognitive Impairment and Dementia: The Chronic Cerebral Hypoperfusion Hypothesis. J Clin Med 2022;11:4742. [PMID: 36012981 DOI: 10.3390/jcm11164742] [Reference Citation Analysis]
5 Chen X, Chen L, Lin G, Wang Z, Kodali MC, Li M, Chen H, Lebovitz SG, Ortyl TC, Li L, Ismael S, Singh P, Malik KU, Ishrat T, Zhou FM, Zheng W, Liao FF. White matter damage as a consequence of vascular dysfunction in a spontaneous mouse model of chronic mild chronic hypoperfusion with eNOS deficiency. Mol Psychiatry 2022. [PMID: 35948662 DOI: 10.1038/s41380-022-01701-9] [Reference Citation Analysis]
6 Winfree RL, Dumitrescu L, Blennow K, Zetterberg H, Gifford KA, Pechman KR, Jefferson AL, Hohman TJ. Biological Correlates of Elevated Soluble TREM2 in 2 Cerebrospinal Fluid. Neurobiology of Aging 2022. [DOI: 10.1016/j.neurobiolaging.2022.06.013] [Reference Citation Analysis]
7 Behl T, Kaur I, Sehgal A, Singh S, Albarrati A, Albratty M, Najmi A, Meraya AM, Bungau S. The road to precision medicine: Eliminating the "One Size Fits All" approach in Alzheimer's disease. Biomed Pharmacother 2022;153:113337. [PMID: 35780617 DOI: 10.1016/j.biopha.2022.113337] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Monti G, Gomes Moreira D, Richner M, Mutsaers HAM, Ferreira N, Jan A. GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight. Cells 2022;11:2023. [DOI: 10.3390/cells11132023] [Reference Citation Analysis]
9 Sharma AL, Wang H, Zhang Z, Millien G, Tyagi M, Hongpaisan J. HIV Promotes Neurocognitive Impairment by Damaging the Hippocampal Microvessels. Mol Neurobiol 2022. [PMID: 35665894 DOI: 10.1007/s12035-022-02890-8] [Reference Citation Analysis]
10 Wu CY, Shapiro L, Ouk M, MacIntosh BJ, Black SE, Shah BR, Swardfager W. Glucose-lowering drugs, cognition, and dementia: The clinical evidence. Neurosci Biobehav Rev 2022;137:104654. [PMID: 35398114 DOI: 10.1016/j.neubiorev.2022.104654] [Reference Citation Analysis]
11 Cosacak MI, Bhattarai P, De Jager PL, Menon V, Tosto G, Kizil C. Single Cell/Nucleus Transcriptomics Comparison in Zebrafish and Humans Reveals Common and Distinct Molecular Responses to Alzheimer’s Disease. Cells 2022;11:1807. [DOI: 10.3390/cells11111807] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Cherbuin N, Walsh EI, Leach L, Brüstle A, Burns R, Anstey KJ, Sachdev PS, Baune BT. Systemic Inflammation Predicts Alzheimer Pathology in Community Samples without Dementia. Biomedicines 2022;10:1240. [DOI: 10.3390/biomedicines10061240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lee AJ, Raghavan NS, Bhattarai P, Siddiqui T, Sariya S, Reyes-Dumeyer D, Flowers XE, Cardoso SAL, De Jager PL, Bennett DA, Schneider JA, Menon V, Wang Y, Lantigua RA, Medrano M, Rivera D, Jiménez-Velázquez IZ, Kukull WA, Brickman AM, Manly JJ, Tosto G, Kizil C, Vardarajan BN, Mayeux R. FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer's disease. Acta Neuropathol 2022. [PMID: 35608697 DOI: 10.1007/s00401-022-02431-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
14 Gannon OJ, Robison LS, Salinero AE, Abi-Ghanem C, Mansour FM, Kelly RD, Tyagi A, Brawley RR, Ogg JD, Zuloaga KL. High-fat diet exacerbates cognitive decline in mouse models of Alzheimer's disease and mixed dementia in a sex-dependent manner. J Neuroinflammation 2022;19:110. [PMID: 35568928 DOI: 10.1186/s12974-022-02466-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
15 Baker J, Schott J. AD and its comorbidities: An obstacle to develop a clinically efficient treatment? Revue Neurologique 2022. [DOI: 10.1016/j.neurol.2022.03.001] [Reference Citation Analysis]
16 Ortiz GG, Huerta M, González-Usigli HA, Torres-Sánchez ED, Delgado-Lara DL, Pacheco-Moisés FP, Mireles-Ramírez MA, Torres-Mendoza BM, Moreno-Cih RI, Velázquez-Brizuela IE. Cognitive disorder and dementia in type 2 diabetes mellitus. World J Diabetes 2022; 13(4): 319-337 [DOI: 10.4239/wjd.v13.i4.319] [Reference Citation Analysis]
17 Costa AS, Ferri E, Guerini FR, Rossi PD, Arosio B, Clerici M. VAMP2 Expression and Genotype Are Possible Discriminators in Different Forms of Dementia. Front Aging Neurosci 2022;14:858162. [DOI: 10.3389/fnagi.2022.858162] [Reference Citation Analysis]
18 You W, Henneberg M. Large household reduces dementia mortality: A cross-sectional data analysis of 183 populations. PLoS One 2022;17:e0263309. [PMID: 35239673 DOI: 10.1371/journal.pone.0263309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Melazzini L, Savoldi F, Chessa M, Vitali P, Zanardo M, Bertoldo EG, Fiolo V, Griffanti L, Carminati M, Frigiola A, Giamberti A, Secchi F, Callus E, Codari M, Sardanelli F. Adults with tetralogy of Fallot show specific features of cerebral small vessel disease: the BACH San Donato study. Brain Imaging Behav 2022. [PMID: 35266099 DOI: 10.1007/s11682-022-00629-6] [Reference Citation Analysis]
20 Panda SP, Soni U. A review of dementia, focusing on the distinct roles of viral protein corona and MMP9 in dementia: Potential pharmacotherapeutic priorities. Ageing Res Rev 2022;75:101560. [PMID: 35031512 DOI: 10.1016/j.arr.2022.101560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Yue Q, Zhou X, Zhang Z, Hoi MPM. Murine Beta-Amyloid (1-42) Oligomers Disrupt Endothelial Barrier Integrity and VEGFR Signaling via Activating Astrocytes to Release Deleterious Soluble Factors. Int J Mol Sci 2022;23:1878. [PMID: 35163801 DOI: 10.3390/ijms23031878] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Tang AS, Oskotsky T, Havaldar S, Mantyh WG, Bicak M, Solsberg CW, Woldemariam S, Zeng B, Hu Z, Oskotsky B, Dubal D, Allen IE, Glicksberg BS, Sirota M. Deep phenotyping of Alzheimer's disease leveraging electronic medical records identifies sex-specific clinical associations. Nat Commun 2022;13:675. [PMID: 35115528 DOI: 10.1038/s41467-022-28273-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Mackenzie JL, Ivanova N, Nell HJ, Giordano CR, Terlecky SR, Agca C, Agca Y, Walton PA, Whitehead SN, Cechetto DF. Microglial inflammation and cognitive dysfunction in comorbid rat models of striatal ischemic stroke and alzheimer’s disease: effects of antioxidant catalase-SKL on behavioral and cellular pathology. Neuroscience 2022. [DOI: 10.1016/j.neuroscience.2022.01.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Wang Y, Huang C, Guo Q, Chu H. Aquaporin-4 and Cognitive Disorders. Aging Dis 2022;13:61-72. [PMID: 35111362 DOI: 10.14336/AD.2021.0731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Lecordier S, Pons V, Rivest S, Elali A. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer’s Disease Pathology in a Sex-Dependent Manner. Front Immunol 2022;12:813536. [DOI: 10.3389/fimmu.2021.813536] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Dallaire-Théroux C, Saikali S, Richer M, Potvin O, Duchesne S. Histopathological Analysis of Cerebrovascular Lesions Associated With Aging. J Neuropathol Exp Neurol 2021:nlab125. [PMID: 34875082 DOI: 10.1093/jnen/nlab125] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Tang Y, Zhang D, Gong X, Zheng J. A mechanistic survey of Alzheimer's disease. Biophys Chem 2021;281:106735. [PMID: 34894476 DOI: 10.1016/j.bpc.2021.106735] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
28 Geerts H, van der Graaf P. Computational Approaches for Supporting Combination Therapy in the Post-Aducanumab Era in Alzheimer’s Disease. ADR 2021;5:815-26. [DOI: 10.3233/adr-210039] [Reference Citation Analysis]
29 Zhou M, Li H, Wang Y, Pan Y, Wang Y. Causal effect of insulin resistance on small vessel stroke and Alzheimer's disease: A Mendelian randomization analysis. Eur J Neurol 2021. [PMID: 34797599 DOI: 10.1111/ene.15190] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
30 Dominguez LJ, Veronese N, Vernuccio L, Catanese G, Inzerillo F, Salemi G, Barbagallo M. Nutrition, Physical Activity, and Other Lifestyle Factors in the Prevention of Cognitive Decline and Dementia. Nutrients 2021;13:4080. [PMID: 34836334 DOI: 10.3390/nu13114080] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
31 Jung Y, Viviano RP, van Rooden S, van der Grond J, Rombouts SARB, Damoiseaux JS. White Matter Hyperintensities and Apolipoprotein E Affect the Association Between Mean Arterial Pressure and Objective and Subjective Cognitive Functioning in Older Adults. J Alzheimers Dis 2021;84:1337-50. [PMID: 34657884 DOI: 10.3233/JAD-210695] [Reference Citation Analysis]
32 Kiselica AM, Kaser AN, Benge JF. An Initial Empirical Operationalization of the Earliest Stages of the Alzheimer's Continuum. Alzheimer Dis Assoc Disord 2021;35:62-7. [PMID: 33009036 DOI: 10.1097/WAD.0000000000000408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Lan YT, Blacker D, Yuan C, Chibnik LB, Hofman A, Ma Y. Longitudinal Body Weight Change, Visit-To-Visit Body Weight Fluctuation, and Cognitive Decline Among Older Adults. J Alzheimers Dis 2021;84:777-86. [PMID: 34569956 DOI: 10.3233/JAD-210625] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Minta K, Brinkmalm G, Portelius E, Johansson P, Svensson J, Kettunen P, Wallin A, Zetterberg H, Blennow K, Andreasson U. Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease. J Alzheimers Dis 2021;79:729-41. [PMID: 33337373 DOI: 10.3233/JAD-201039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
35 Wong FCC, Saffari SE, Yatawara C, Ng KP, Kandiah N; Alzheimer’s Disease Neuroimaging Initiative. Influence of White Matter Hyperintensities on Baseline and Longitudinal Amyloid-β in Cognitively Normal Individuals. J Alzheimers Dis 2021;84:91-101. [PMID: 34511497 DOI: 10.3233/JAD-210333] [Reference Citation Analysis]
36 Chong JR, Ashton NJ, Karikari TK, Tanaka T, Schöll M, Zetterberg H, Blennow K, Chen CP, Lai MKP. Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances. J Neurol Neurosurg Psychiatry 2021;92:1231-41. [PMID: 34510001 DOI: 10.1136/jnnp-2021-327370] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
37 Trigiani LJ, Bourourou M, Lacalle-Aurioles M, Lecrux C, Hynes A, Spring S, Fernandes DJ, Sled JG, Lesage F, Schwaninger M, Hamel E. A functional cerebral endothelium is necessary to protect against cognitive decline. J Cereb Blood Flow Metab 2021;:271678X211045438. [PMID: 34515549 DOI: 10.1177/0271678X211045438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Reveglia P, Paolillo C, Ferretti G, De Carlo A, Angiolillo A, Nasso R, Caputo M, Matrone C, Di Costanzo A, Corso G. Challenges in LC-MS-based metabolomics for Alzheimer's disease early detection: targeted approaches versus untargeted approaches. Metabolomics 2021;17:78. [PMID: 34453619 DOI: 10.1007/s11306-021-01828-w] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
39 Priemer DS, Folkerth RD. Dementia in the Forensic Setting: Diagnoses Obtained Using a Condensed Protocol at the Office of Chief Medical Examiner, New York City. J Neuropathol Exp Neurol 2021:nlab059. [PMID: 34388235 DOI: 10.1093/jnen/nlab059] [Reference Citation Analysis]
40 Scarth M, Rissanen I, Scholten RJPM, Geerlings MI. Biomarkers of Alzheimer's Disease and Cerebrovascular Lesions and Clinical Progression in Patients with Subjective Cognitive Decline: A Systematic Review. J Alzheimers Dis 2021. [PMID: 34397412 DOI: 10.3233/JAD-210218] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
41 Beishon L, Panerai RB, Robinson TG, Haunton VJ. Cerebral blood flow response rate to task-activation using a novel method can discriminate cognitive impairment from healthy aging. Physiol Meas 2021;42. [PMID: 34229305 DOI: 10.1088/1361-6579/ac1185] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
42 Garg PK, Tan AX, Odden MC, Gardin JM, Lopez OL, Newman AB, Rawlings AM, Mukamal KJ. Brachial Flow-mediated Dilation and Risk of Dementia: The Cardiovascular Health Study. Alzheimer Dis Assoc Disord 2020;34:272-4. [PMID: 32483019 DOI: 10.1097/WAD.0000000000000394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Song R, Pan KY, Xu H, Qi X, Buchman AS, Bennett DA, Xu W. Association of cardiovascular risk burden with risk of dementia and brain pathologies: A population-based cohort study. Alzheimers Dement 2021. [PMID: 34310004 DOI: 10.1002/alz.12343] [Reference Citation Analysis]
44 Schoemaker D, Velilla-Jimenez L, Zuluaga Y, Baena A, Ospina C, Bocanegra Y, Alvarez S, Ochoa-Escudero M, Guzmán-Vélez E, Martinez J, Lopera F, Arboleda-Velasquez JF, Quiroz YT. Global Cardiovascular Risk Profile and Cerebrovascular Abnormalities in Presymptomatic Individuals with CADASIL or Autosomal Dominant Alzheimer's Disease. J Alzheimers Dis 2021;82:841-53. [PMID: 34092645 DOI: 10.3233/JAD-210313] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Babić Leko M, Jurasović J, Nikolac Perković M, Španić E, Sekovanić A, Orct T, Lukinović Škudar V, Bačić Baronica K, Kiđemet-Piskač S, Vogrinc Ž, Pivac N, Borovečki F, Hof PR, Šimić G. The Association of Essential Metals with APOE Genotype in Alzheimer's Disease. J Alzheimers Dis 2021;82:661-72. [PMID: 34057084 DOI: 10.3233/JAD-210158] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
46 Hendriks S, Peetoom K, Bakker C, van der Flier WM, Papma JM, Koopmans R, Verhey FRJ, de Vugt M, Köhler S, Withall A, Parlevliet JL, Uysal-Bozkir Ö, Gibson RC, Neita SM, Nielsen TR, Salem LC, Nyberg J, Lopes MA, Dominguez JC, De Guzman MF, Egeberg A, Radford K, Broe T, Subramaniam M, Abdin E, Bruni AC, Di Lorenzo R, Smith K, Flicker L, Mol MO, Basta M, Yu D, Masika G, Petersen MS, Ruano L; Young-Onset Dementia Epidemiology Study Group. Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis. JAMA Neurol 2021. [PMID: 34279544 DOI: 10.1001/jamaneurol.2021.2161] [Cited by in F6Publishing: 27] [Reference Citation Analysis]
47 Tan LY, Yeo XY, Bae HG, Lee DPS, Ho RC, Kim JE, Jo DG, Jung S. Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases? Life (Basel) 2021;11:698. [PMID: 34357070 DOI: 10.3390/life11070698] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
48 Duplantier SC, Gardner CD. A Critical Review of the Study of Neuroprotective Diets to Reduce Cognitive Decline. Nutrients 2021;13:2264. [PMID: 34208980 DOI: 10.3390/nu13072264] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
49 Popescu A, German M. Vitamin K2 Holds Promise for Alzheimer's Prevention and Treatment. Nutrients 2021;13:2206. [PMID: 34199021 DOI: 10.3390/nu13072206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
50 Ding D, Wang X, Li Q, Li L, Wu J. Research on the Glial-Lymphatic System and Its Relationship With Alzheimer's Disease. Front Neurosci 2021;15:605586. [PMID: 34220413 DOI: 10.3389/fnins.2021.605586] [Reference Citation Analysis]
51 Garrigue P, Mounien L, Champion S, Mouhajir Y, Pechere L, Guillet B, Landrier JF, Seree E. Long-term administration of resveratrol at low doses improves neurocognitive performance as well as cerebral blood flow and modulates the inflammatory pathways in the brain. J Nutr Biochem 2021;97:108786. [PMID: 34082127 DOI: 10.1016/j.jnutbio.2021.108786] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Bir SC, Khan MW, Javalkar V, Toledo EG, Kelley RE. Emerging Concepts in Vascular Dementia: A Review. J Stroke Cerebrovasc Dis 2021;30:105864. [PMID: 34062312 DOI: 10.1016/j.jstrokecerebrovasdis.2021.105864] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
53 Mendes FR, Leclerc JL, Liu L, Kamat PK, Naziripour A, Hernandez D, Li C, Ahmad AS, Doré S. Effect of Experimental Ischemic Stroke and PGE2 EP1 Selective Antagonism in Alzheimer's Disease Mouse Models. J Alzheimers Dis 2020;74:173-87. [PMID: 31985468 DOI: 10.3233/JAD-191069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Elahi FM, Ashimatey SB, Bennett DJ, Walters SM, La Joie R, Jiang X, Wolf A, Cobigo Y, Staffaroni AM, Rosen HJ, Miller BL, Rabinovici GD, Kramer JH, Green AJ, Kashani AH. Retinal imaging demonstrates reduced capillary density in clinically unimpaired APOE ε4 gene carriers. Alzheimers Dement (Amst) 2021;13:e12181. [PMID: 34013017 DOI: 10.1002/dad2.12181] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Paolini Paoletti F, Simoni S, Parnetti L, Gaetani L. The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis. Int J Mol Sci 2021;22:4958. [PMID: 34066951 DOI: 10.3390/ijms22094958] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
56 Jang H, Kim HJ, Choe YS, Kim SJ, Park S, Kim Y, Kim KW, Lyoo CH, Cho H, Ryu YH, Choi JY, DeCarli C, Na DL, Seo SW; Alzheimer’s Disease Neuroimaging Initiative. The Impact of Amyloid-β or Tau on Cognitive Change in the Presence of Severe Cerebrovascular Disease. J Alzheimers Dis 2020;78:573-85. [PMID: 33016911 DOI: 10.3233/JAD-200680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Wang YJ, Hu H, Yang YX, Zuo CT, Tan L, Yu JT; Alzheimer’s Disease Neuroimaging Initiative. Regional Amyloid Accumulation and White Matter Integrity in Cognitively Normal Individuals. J Alzheimers Dis 2020;74:1261-70. [PMID: 32176644 DOI: 10.3233/JAD-191350] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Singh PK, Badimon A, Chen ZL, Strickland S, Norris EH. The contact activation system and vascular factors as alternative targets for Alzheimer's disease therapy. Res Pract Thromb Haemost 2021;5:e12504. [PMID: 33977208 DOI: 10.1002/rth2.12504] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Abyadeh M, Gupta V, Chitranshi N, Gupta V, Wu Y, Saks D, Wander Wall R, Fitzhenry MJ, Basavarajappa D, You Y, Salekdeh GH, Haynes PA, Graham SL, Mirzaei M. Mitochondrial dysfunction in Alzheimer's disease - a proteomics perspective. Expert Rev Proteomics 2021;18:295-304. [PMID: 33874826 DOI: 10.1080/14789450.2021.1918550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
60 Beishon LC, Panerai RB, Budgeon C, Subramaniam H, Mukaetova-Ladinska E, Robinson TG, Haunton VJ. The Cognition and Flow Study: A Feasibility Randomized Controlled Trial of the Effects of Cognitive Training on Cerebral Blood Flow. J Alzheimers Dis 2021;80:1567-81. [PMID: 33720895 DOI: 10.3233/JAD-201444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
61 O'Shea DM, Thomas KR, Asken B, Lee AKW, Davis JD, Malloy PF, Salloway SP, Correia S; Alzheimer's Disease Neuroimaging Initiative. Adding cognition to AT(N) models improves prediction of cognitive and functional decline. Alzheimers Dement (Amst) 2021;13:e12174. [PMID: 33816757 DOI: 10.1002/dad2.12174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Ribeiro VT, Cordeiro TME, Filha RDS, Perez LG, Caramelli P, Teixeira AL, de Souza LC, Simões E Silva AC. Circulating Angiotensin-(1-7) Is Reduced in Alzheimer's Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study. Front Neurosci 2021;15:636754. [PMID: 33897352 DOI: 10.3389/fnins.2021.636754] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
63 Unzeta M, Hernàndez-Guillamon M, Sun P, Solé M. SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease. Int J Mol Sci 2021;22:3365. [PMID: 33805974 DOI: 10.3390/ijms22073365] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
64 Ferreira ST. Brain insulin, insulin-like growth factor 1 and glucagon-like peptide 1 signalling in Alzheimer's disease. J Neuroendocrinol 2021;33:e12959. [PMID: 33739563 DOI: 10.1111/jne.12959] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
65 Lim MJR, Tan CS, Gyanwali B, Chen C, Hilal S. The effect of intracranial stenosis on cognitive decline in a memory clinic cohort. Eur J Neurol 2021;28:1829-39. [PMID: 33630355 DOI: 10.1111/ene.14788] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Krishnamurthy V, Sprick JD, Krishnamurthy LC, Barter JD, Turabi A, Hajjar IM, Nocera JR. The Utility of Cerebrovascular Reactivity MRI in Brain Rehabilitation: A Mechanistic Perspective. Front Physiol 2021;12:642850. [PMID: 33815146 DOI: 10.3389/fphys.2021.642850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
67 Asby D, Boche D, Allan S, Love S, Miners JS. Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease. Brain 2021;144:1869-83. [PMID: 33723589 DOI: 10.1093/brain/awab094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
68 Drake JD, Chambers AB, Ott BR, Daiello LA; Alzheimer’s Disease Neuroimaging Initiative. Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease. J Alzheimers Dis 2021;80:1553-65. [PMID: 33720880 DOI: 10.3233/JAD-200759] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
69 Disbrow E, Stokes KY, Ledbetter C, Patterson J, Kelley R, Pardue S, Reekes T, Larmeu L, Batra V, Yuan S, Cvek U, Trutschl M, Kilgore P, Alexander JS, Kevil CG. Plasma hydrogen sulfide: A biomarker of Alzheimer's disease and related dementias. Alzheimers Dement 2021;17:1391-402. [PMID: 33710769 DOI: 10.1002/alz.12305] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
70 Kim MS, Bang J, Kim BY, Jeon WK. Impaired Cognitive Flexibility Induced by Chronic Cerebral Hypoperfusion in the 5XFAD Transgenic Mouse Model of Mixed Dementia. J Gerontol A Biol Sci Med Sci 2021;76:1169-78. [PMID: 33709149 DOI: 10.1093/gerona/glab075] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
71 Liao FF, Lin G, Chen X, Chen L, Zheng W, Raghow R, Zhou FM, Shih AY, Tan XL. Endothelial Nitric Oxide Synthase-Deficient Mice. Am J Pathol 2021:S0002-9440(21)00102-4. [PMID: 33711310 DOI: 10.1016/j.ajpath.2021.02.022] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
72 Button EB, Cheng WH, Barron C, Cheung H, Bashir A, Cooper J, Gill J, Stukas S, Baron DC, Robert J, Rowe EM, Cripton PA, Wellington CL. Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury. Alzheimers Res Ther 2021;13:58. [PMID: 33678186 DOI: 10.1186/s13195-021-00793-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 McAleese KE, Colloby SJ, Thomas AJ, Al-Sarraj S, Ansorge O, Neal J, Roncaroli F, Love S, Francis PT, Attems J. Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia. Alzheimers Dement 2021;17:1121-33. [PMID: 33663011 DOI: 10.1002/alz.12291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
74 Nag N, Lin X, Yu M, Simpson-Yap S, Jelinek GA, Neate SL, Levin M. Assessing Lifestyle Behaviours of People Living with Neurological Conditions: A Panoramic View of Community Dwelling Australians from 2007-2018. J Pers Med 2021;11:144. [PMID: 33669547 DOI: 10.3390/jpm11020144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 González-Molina LA, Villar-Vesga J, Henao-Restrepo J, Villegas A, Lopera F, Cardona-Gómez GP, Posada-Duque R. Extracellular Vesicles From 3xTg-AD Mouse and Alzheimer's Disease Patient Astrocytes Impair Neuroglial and Vascular Components. Front Aging Neurosci 2021;13:593927. [PMID: 33679370 DOI: 10.3389/fnagi.2021.593927] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
76 Waller R, Narramore R, Simpson JE, Heath PR, Verma N, Tinsley M, Barnes JR, Haris HT, Henderson FE, Matthews FE, Richardson CD, Brayne C, Ince PG, Kalaria RN, Wharton SB; CFAS. Heterogeneity of cellular inflammatory responses in ageing white matter and relationship to Alzheimer's and small vessel disease pathologies. Brain Pathol 2021;31:e12928. [PMID: 33336479 DOI: 10.1111/bpa.12928] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
77 Mehta RI, Schneider JA. What is 'Alzheimer's disease'? The neuropathological heterogeneity of clinically defined Alzheimer's dementia. Curr Opin Neurol 2021;34:237-45. [PMID: 33591030 DOI: 10.1097/WCO.0000000000000912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
78 Bone WP, Siewert KM, Jha A, Klarin D, Damrauer SM, Chang KM, Tsao PS, Assimes TL, Ritchie MD, Voight BF; VA Million Veteran Program. Multi-trait association studies discover pleiotropic loci between Alzheimer's disease and cardiometabolic traits. Alzheimers Res Ther 2021;13:34. [PMID: 33541420 DOI: 10.1186/s13195-021-00773-z] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
79 Wang R, Qiu C, Dintica CS, Shang Y, Calderón Larrañaga A, Wang HX, Xu W. Shared risk and protective factors between Alzheimer's disease and ischemic stroke: A population-based longitudinal study. Alzheimers Dement 2021;17:191-204. [PMID: 33527694 DOI: 10.1002/alz.12203] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
80 Meakin PJ, Coull BM, Tuharska Z, McCaffery C, Akoumianakis I, Antoniades C, Brown J, Griffin KJ, Platt F, Ozber CH, Yuldasheva NY, Makava N, Skromna A, Prescott A, McNeilly AD, Siddiqui M, Palmer CN, Khan F, Ashford ML. Elevated circulating amyloid concentrations in obesity and diabetes promote vascular dysfunction. J Clin Invest 2020;130:4104-17. [PMID: 32407295 DOI: 10.1172/JCI122237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
81 Sharma MJ, Callahan BL. Cerebrovascular and Neurodegenerative Pathologies in Long-Term Stable Mild Cognitive Impairment. J Alzheimers Dis 2021;79:1269-83. [PMID: 33427736 DOI: 10.3233/JAD-200829] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Solovyev N, El-Khatib AH, Costas-Rodríguez M, Schwab K, Griffin E, Raab A, Platt B, Theuring F, Vogl J, Vanhaecke F. Cu, Fe, and Zn isotope ratios in murine Alzheimer's disease models suggest specific signatures of amyloidogenesis and tauopathy. J Biol Chem 2021;296:100292. [PMID: 33453282 DOI: 10.1016/j.jbc.2021.100292] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
83 Tian J, Smith G, Guo H, Liu B, Pan Z, Wang Z, Xiong S, Fang R. Modular machine learning for Alzheimer's disease classification from retinal vasculature. Sci Rep 2021;11:238. [PMID: 33420208 DOI: 10.1038/s41598-020-80312-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
84 Grande G, Marengoni A, Vetrano DL, Roso-Llorach A, Rizzuto D, Zucchelli A, Qiu C, Fratiglioni L, Calderón-Larrañaga A. Multimorbidity burden and dementia risk in older adults: The role of inflammation and genetics. Alzheimers Dement 2021;17:768-76. [PMID: 33403740 DOI: 10.1002/alz.12237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
85 Lowry E, Puthusseryppady V, Johnen A, Renoult L, Hornberger M. Cognitive and neuroimaging markers for preclinical vascular cognitive impairment. Cerebral Circulation - Cognition and Behavior 2021;2:100029. [DOI: 10.1016/j.cccb.2021.100029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Charisis S, Ntanasi E, Yannakoulia M, Anastasiou C, Kosmidis M, Dardiotis E, Hadjigeorgiou G, Sakka P, Veskoukis A, Kouretas D, Scarmeas N. Plasma GSH levels and Alzheimer's disease. A prospective approach.: Results from the HELIAD study. Free Radical Biology and Medicine 2021;162:274-82. [DOI: 10.1016/j.freeradbiomed.2020.10.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
87 Jung J, Bae SH, Han JH, Kwak SH, Nam GS, Lee PH, Sohn YH, Yun M, Ye BS. Relationship between Hearing Loss and Dementia Differs According to the Underlying Mechanism. J Clin Neurol 2021;17:290-9. [PMID: 33835751 DOI: 10.3988/jcn.2021.17.2.290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Leibing A. Situated Prevention: Framing the “New Dementia”. J Law Med Ethics 2018;46:704-16. [DOI: 10.1177/1073110518804232] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
89 Miners S, Kehoe PG, Love S. Cognitive impact of COVID-19: looking beyond the short term. Alzheimers Res Ther 2020;12:170. [PMID: 33380345 DOI: 10.1186/s13195-020-00744-w] [Cited by in Crossref: 21] [Cited by in F6Publishing: 63] [Article Influence: 10.5] [Reference Citation Analysis]
90 Zhuang L, Ni H, Wang J, Liu X, Lin Y, Su Y, Zhang K, Li Y, Peng G, Luo B. Aggregation of Vascular Risk Factors Modulates the Amplitude of Low-Frequency Fluctuation in Mild Cognitive Impairment Patients. Front Aging Neurosci 2020;12:604246. [PMID: 33408627 DOI: 10.3389/fnagi.2020.604246] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
91 Beyer L, Brendel M. Imaging of Tau Pathology in Neurodegenerative Diseases: An Update. Semin Nucl Med 2021;51:253-63. [PMID: 33353724 DOI: 10.1053/j.semnuclmed.2020.12.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
92 Ribeiro VT, de Souza LC, Simões E Silva AC. Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives. Protein Pept Lett 2020;27:484-511. [PMID: 31886744 DOI: 10.2174/0929866527666191230103739] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
93 Kim YW, Al-Ramahi I, Koire A, Wilson SJ, Konecki DM, Mota S, Soleimani S, Botas J, Lichtarge O. Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's disease. Alzheimers Dement 2021;17:831-46. [PMID: 33576571 DOI: 10.1002/alz.12240] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
94 Parodi-Rullán R, Sone JY, Fossati S. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease. J Alzheimers Dis 2019;72:1019-39. [PMID: 31306129 DOI: 10.3233/JAD-190357] [Cited by in Crossref: 23] [Cited by in F6Publishing: 34] [Article Influence: 11.5] [Reference Citation Analysis]
95 Heldt NA, Reichenbach N, McGary HM, Persidsky Y. Effects of Electronic Nicotine Delivery Systems and Cigarettes on Systemic Circulation and Blood-Brain Barrier: Implications for Cognitive Decline. Am J Pathol 2021;191:243-55. [PMID: 33285126 DOI: 10.1016/j.ajpath.2020.11.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
96 Marsillach J, Adorni MP, Zimetti F, Papotti B, Zuliani G, Cervellati C. HDL Proteome and Alzheimer's Disease: Evidence of a Link. Antioxidants (Basel) 2020;9:E1224. [PMID: 33287338 DOI: 10.3390/antiox9121224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
97 Howe MD, McCullough LD, Urayama A. The Role of Basement Membranes in Cerebral Amyloid Angiopathy. Front Physiol 2020;11:601320. [PMID: 33329053 DOI: 10.3389/fphys.2020.601320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
98 Kim HJ, Park J, Kim YS, Park J. The sex-specific effect of the apolipoprotein E allele and methylenetetrahydrofolate reductase gene polymorphism on the biochemical, anatomical, and cognitive profiles of patients clinically diagnosed with probable Alzheimer's disease. Int J Geriatr Psychiatry 2021;36:588-97. [PMID: 33166415 DOI: 10.1002/gps.5458] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Robert J, Weilinger NL, Cao LP, Cataldi S, Button EB, Stukas S, Martin EM, Seibler P, Gilmour M, Caffrey TM, Rowe EM, Fan J, MacVicar B, Farrer MJ, Wellington CL. An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases. Mol Neurodegener 2020;15:70. [PMID: 33213497 DOI: 10.1186/s13024-020-00418-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
100 Chua XY, Ho LTY, Xiang P, Chew WS, Lam BWS, Chen CP, Ong WY, Lai MKP, Herr DR. Preclinical and Clinical Evidence for the Involvement of Sphingosine 1-Phosphate Signaling in the Pathophysiology of Vascular Cognitive Impairment. Neuromolecular Med 2021;23:47-67. [PMID: 33180310 DOI: 10.1007/s12017-020-08632-0] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
101 Del Prete E, Beatino MF, Campese N, Giampietri L, Siciliano G, Ceravolo R, Baldacci F. Fluid Candidate Biomarkers for Alzheimer's Disease: A Precision Medicine Approach. J Pers Med 2020;10:E221. [PMID: 33187336 DOI: 10.3390/jpm10040221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
102 Toppala S, Ekblad LL, Lötjönen J, Helin S, Hurme S, Johansson J, Jula A, Karrasch M, Koikkalainen J, Laine H, Parkkola R, Viitanen M, Rinne JO. Midlife Insulin Resistance as a Predictor for Late-Life Cognitive Function and Cerebrovascular Lesions. J Alzheimers Dis 2019;72:215-28. [PMID: 31561373 DOI: 10.3233/JAD-190691] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
103 Lee JS, Lee H, Park S, Choe Y, Park YH, Cheon BK, Hahn A, Ossenkoppele R, Kim HJ, Kim S, Yoo H, Jang H, Cho SH, Kim SJ, Kim JP, Jung YH, Park KC, DeCarli C, Weiner MW, Na DL, Seo SW. Association between APOE ε2 and Aβ burden in patients with Alzheimer- and vascular-type cognitive impairment. Neurology 2020;95:e2354-65. [PMID: 32928967 DOI: 10.1212/WNL.0000000000010811] [Reference Citation Analysis]
104 Posada-Duque RA, Cardona-Gómez GP. CDK5 Targeting as a Therapy for Recovering Neurovascular Unit Integrity in Alzheimer's Disease. J Alzheimers Dis 2021;82:S141-61. [PMID: 33016916 DOI: 10.3233/JAD-200730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
105 Czakó C, Kovács T, Ungvari Z, Csiszar A, Yabluchanskiy A, Conley S, Csipo T, Lipecz A, Horváth H, Sándor GL, István L, Logan T, Nagy ZZ, Kovács I. Retinal biomarkers for Alzheimer's disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis. Geroscience 2020;42:1499-525. [PMID: 33011937 DOI: 10.1007/s11357-020-00252-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
106 Kelly SC, McKay EC, Beck JS, Collier TJ, Dorrance AM, Counts SE. Locus Coeruleus Degeneration Induces Forebrain Vascular Pathology in a Transgenic Rat Model of Alzheimer's Disease. J Alzheimers Dis 2019;70:371-88. [PMID: 31177220 DOI: 10.3233/JAD-190090] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
107 Chua XY, Chai YL, Chew WS, Chong JR, Ang HL, Xiang P, Camara K, Howell AR, Torta F, Wenk MR, Hilal S, Venketasubramanian N, Chen CP, Herr DR, Lai MKP. Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairment. Alzheimers Res Ther 2020;12:122. [PMID: 32998767 DOI: 10.1186/s13195-020-00694-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
108 Watanabe C, Imaizumi T, Kawai H, Suda K, Honma Y, Ichihashi M, Ema M, Mizutani KI. Aging of the Vascular System and Neural Diseases. Front Aging Neurosci 2020;12:557384. [PMID: 33132896 DOI: 10.3389/fnagi.2020.557384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
109 Pettigrew C, Soldan A, Wang J, Wang MC, Arthur K, Moghekar A, Gottesman RF, Albert M. Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline. Neurology 2020;95:e3093-103. [PMID: 32989109 DOI: 10.1212/WNL.0000000000010946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
110 Blue EE, Thornton TA, Kooperberg C, Liu S, Wactawski-Wende J, Manson J, Kuller L, Hayden K, Reiner AP. Non-coding variants in MYH11, FZD3, and SORCS3 are associated with dementia in women. Alzheimers Dement 2021;17:215-25. [PMID: 32966694 DOI: 10.1002/alz.12181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
111 Pålhaugen L, Sudre CH, Tecelao S, Nakling A, Almdahl IS, Kalheim LF, Cardoso MJ, Johnsen SH, Rongve A, Aarsland D, Bjørnerud A, Selnes P, Fladby T. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns. J Cereb Blood Flow Metab 2021;41:1162-74. [PMID: 32955960 DOI: 10.1177/0271678X20957604] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
112 Blanken AE, Dutt S, Li Y, Nation DA; Alzheimer’s Disease Neuroimaging Initiative. Disentangling Heterogeneity in Alzheimer's Disease: Two Empirically-Derived Subtypes. J Alzheimers Dis 2019;70:227-39. [PMID: 31177226 DOI: 10.3233/JAD-190230] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
113 Osborn KE, Alverio JM, Dumitrescu L, Pechman KR, Gifford KA, Hohman TJ, Blennow K, Zetterberg H, Jefferson AL; Alzheimer’s Disease Neuroimaging Initiative. Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology. J Alzheimers Dis 2019;71:281-90. [PMID: 31381510 DOI: 10.3233/JAD-190077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
114 McGurran H, Glenn JM, Madero EN, Bott NT. Prevention and Treatment of Alzheimer's Disease: Biological Mechanisms of Exercise. J Alzheimers Dis 2019;69:311-38. [PMID: 31104021 DOI: 10.3233/JAD-180958] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
115 Rayaprolu S, Higginbotham L, Bagchi P, Watson CM, Zhang T, Levey AI, Rangaraju S, Seyfried NT. Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau. Neuropsychopharmacology 2021;46:98-115. [PMID: 32898852 DOI: 10.1038/s41386-020-00840-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
116 Simões-Pires EN, Ferreira ST, Linden R. Roles of glutamate receptors in a novel in vitro model of early, comorbid cerebrovascular, and Alzheimer's diseases. J Neurochem 2021;156:539-52. [PMID: 32683713 DOI: 10.1111/jnc.15129] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Bennett RE, Hu M, Fernandes A, Perez-Rando M, Robbins A, Kamath T, Dujardin S, Hyman BT. Tau reduction in aged mice does not impact Microangiopathy. Acta Neuropathol Commun 2020;8:137. [PMID: 32811565 DOI: 10.1186/s40478-020-01014-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Maliszewska-Cyna E, Vecchio LM, Thomason LAM, Oore JJ, Steinman J, Joo IL, Dorr A, McLaurin J, Sled JG, Stefanovic B, Aubert I. The effects of voluntary running on cerebrovascular morphology and spatial short-term memory in a mouse model of amyloidosis. Neuroimage 2020;222:117269. [PMID: 32818618 DOI: 10.1016/j.neuroimage.2020.117269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
119 Chibhabha F, Yaqi Y, Li F. Retinal involvement in Alzheimer's disease (AD): evidence and current progress on the non-invasive diagnosis and monitoring of AD-related pathology using the eye. Rev Neurosci 2020:/j/revneuro. [PMID: 32804680 DOI: 10.1515/revneuro-2019-0119] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Ho KKHY, Ferruzzi MG, Wightman JD. Potential health benefits of (poly)phenols derived from fruit and 100% fruit juice. Nutr Rev 2020;78:145-74. [PMID: 31532485 DOI: 10.1093/nutrit/nuz041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
121 O'Caoimh R, Gao Y, Svendrovski A, Illario M, Iaccarino G, Yavuz BB, Kehoe PG, Molloy DW. Effect of Visit-to-Visit Blood Pressure Variability on Cognitive and Functional Decline in Mild to Moderate Alzheimer's Disease. J Alzheimers Dis 2019;68:1499-510. [PMID: 30909214 DOI: 10.3233/JAD-180774] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
122 Rafnsson SB, Orrell M, d'Orsi E, Hogervorst E, Steptoe A. Loneliness, Social Integration, and Incident Dementia Over 6 Years: Prospective Findings From the English Longitudinal Study of Ageing. J Gerontol B Psychol Sci Soc Sci 2020;75:114-24. [PMID: 28658937 DOI: 10.1093/geronb/gbx087] [Cited by in Crossref: 64] [Cited by in F6Publishing: 82] [Article Influence: 32.0] [Reference Citation Analysis]
123 Lee NK, Kim H, Chang JW, Jang H, Kim H, Yang J, Kim J, Son JP, Na DL. Exploring the Potential of Mesenchymal Stem Cell-Based Therapy in Mouse Models of Vascular Cognitive Impairment. Int J Mol Sci 2020;21:E5524. [PMID: 32752272 DOI: 10.3390/ijms21155524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
124 Smargiassi A, Sidi EAL, Robert LE, Plante C, Haddad M, Gamache P, Burnett R, Goudreau S, Liu L, Fournier M, Pelletier E, Yankoty I. Exposure to ambient air pollutants and the onset of dementia in Québec, Canada. Environ Res 2020;190:109870. [PMID: 32739624 DOI: 10.1016/j.envres.2020.109870] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
125 Soldan A, Pettigrew C, Zhu Y, Wang MC, Gottesman RF, DeCarli C, Albert M; BIOCARD Research Team. Cognitive reserve and midlife vascular risk: Cognitive and clinical outcomes. Ann Clin Transl Neurol 2020;7:1307-17. [PMID: 32856790 DOI: 10.1002/acn3.51120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
126 Hickman RA, Flowers XE, Wisniewski T. Primary Age-Related Tauopathy (PART): Addressing the Spectrum of Neuronal Tauopathic Changes in the Aging Brain. Curr Neurol Neurosci Rep 2020;20:39. [PMID: 32666342 DOI: 10.1007/s11910-020-01063-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
127 D'Angelo C, Goldeck D, Pawelec G, Gaspari L, Di Iorio A, Paganelli R. Exploratory study on immune phenotypes in Alzheimer's disease and vascular dementia. Eur J Neurol 2020;27:1887-94. [PMID: 32441872 DOI: 10.1111/ene.14360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
128 Fransquet PD, Lacaze P, Saffery R, Phung J, Parker E, Shah R, Murray A, Woods RL, Ryan J. Blood DNA methylation signatures to detect dementia prior to overt clinical symptoms. Alzheimers Dement (Amst) 2020;12:e12056. [PMID: 32671182 DOI: 10.1002/dad2.12056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
129 Semba RD. Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease. Adv Nutr 2020;11:760-72. [PMID: 32190891 DOI: 10.1093/advances/nmaa024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
130 Mullane K, Williams M. Alzheimer’s disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery? Biochemical Pharmacology 2020;177:113945. [DOI: 10.1016/j.bcp.2020.113945] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
131 Abi-Ghanem C, Robison LS, Zuloaga KL. Androgens' effects on cerebrovascular function in health and disease. Biol Sex Differ 2020;11:35. [PMID: 32605602 DOI: 10.1186/s13293-020-00309-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
132 Stracke S, Lange S, Bornmann S, Kock H, Schulze L, Klinger-König J, Böhm S, Vogelgesang A, von Podewils F, Föel A, Gross S, Wenzel K, Wallukat G, Prüss H, Dressel A, Kunze R, Grabe HJ, Langner S, Dörr M. Immunoadsorption for Treatment of Patients with Suspected Alzheimer Dementia and Agonistic Autoantibodies against Alpha1a-Adrenoceptor-Rationale and Design of the IMAD Pilot Study. J Clin Med 2020;9:E1919. [PMID: 32575439 DOI: 10.3390/jcm9061919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
133 Snyder HM, Bain LJ, Brickman AM, Carrillo MC, Esbensen AJ, Espinosa JM, Fernandez F, Fortea J, Hartley SL, Head E, Hendrix J, Kishnani PS, Lai F, Lao P, Lemere C, Mobley W, Mufson EJ, Potter H, Zaman SH, Granholm AC, Rosas HD, Strydom A, Whitten MS, Rafii MS. Further understanding the connection between Alzheimer's disease and Down syndrome. Alzheimers Dement 2020;16:1065-77. [PMID: 32544310 DOI: 10.1002/alz.12112] [Cited by in Crossref: 11] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
134 Zeng F, Liu Y, Huang W, Qing H, Kadowaki T, Kashiwazaki H, Ni J, Wu Z. Receptor for advanced glycation end products up-regulation in cerebral endothelial cells mediates cerebrovascular-related amyloid β accumulation after Porphyromonas gingivalis infection. J Neurochem 2021;158:724-36. [PMID: 32441775 DOI: 10.1111/jnc.15096] [Cited by in Crossref: 10] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
135 Rosa G, Giannotti C, Martella L, Massa F, Serafini G, Pardini M, Nobili FM, Monacelli F, Mecocci P; for the Disease Management Team on Dementia of the IRCCS Ospedale Policlinico San Martino (Genoa, I). Brain Aging, Cardiovascular Diseases, Mixed Dementia, and Frailty in the Oldest Old: From Brain Phenotype to Clinical Expression. JAD 2020;75:1083-103. [DOI: 10.3233/jad-191075] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
136 McKay EC, Beck JS, Khoo SK, Dykema KJ, Cottingham SL, Winn ME, Paulson HL, Lieberman AP, Counts SE. Peri-Infarct Upregulation of the Oxytocin Receptor in Vascular Dementia. J Neuropathol Exp Neurol 2019;78:436-52. [PMID: 30990880 DOI: 10.1093/jnen/nlz023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
137 Petersen M, Frey BM, Schlemm E, Mayer C, Hanning U, Engelke K, Fiehler J, Borof K, Jagodzinski A, Gerloff C, Thomalla G, Cheng B. Network Localisation of White Matter Damage in Cerebral Small Vessel Disease. Sci Rep 2020;10:9210. [PMID: 32514044 DOI: 10.1038/s41598-020-66013-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
138 Button EB, Robert J, Caffrey TM, Fan J, Zhao W, Wellington CL. HDL from an Alzheimer's disease perspective. Curr Opin Lipidol 2019;30:224-34. [PMID: 30946049 DOI: 10.1097/MOL.0000000000000604] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 19.5] [Reference Citation Analysis]
139 Pahlavian SH, Wang X, Ma S, Zheng H, Casey M, D'Orazio LM, Shao X, Ringman JM, Chui H, Wang DJ, Yan L. Cerebroarterial pulsatility and resistivity indices are associated with cognitive impairment and white matter hyperintensity in elderly subjects: A phase-contrast MRI study. J Cereb Blood Flow Metab 2021;41:670-83. [PMID: 32501154 DOI: 10.1177/0271678X20927101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
140 Zhou B, Li L, Qiu X, Wu J, Xu L, Shao W. Long non-coding RNA ANRIL knockdown suppresses apoptosis and pro-inflammatory cytokines while enhancing neurite outgrowth via binding microRNA-125a in a cellular model of Alzheimer's disease. Mol Med Rep 2020;22:1489-97. [PMID: 32626959 DOI: 10.3892/mmr.2020.11203] [Cited by in Crossref: 8] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
141 Cable J, Holtzman DM, Hyman BT, Tansey MG, Colonna M, Kellis M, Brinton RD, Albert M, Wellington CL, Sisodia SS, Tanzi RE. Alternatives to amyloid for Alzheimer's disease therapies-a symposium report. Ann N Y Acad Sci 2020;1475:3-14. [PMID: 32472577 DOI: 10.1111/nyas.14371] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
142 Chiu WT, Lee TY, Chan L, Wu D, Huang LK, Chen DY, Lee YT, Hu CJ, Hong CT. Deep cerebral microbleeds are associated with poor cholinesterase inhibitor treatment response in people with Alzheimer disease. Clin Neurol Neurosurg 2020;195:105959. [PMID: 32480198 DOI: 10.1016/j.clineuro.2020.105959] [Reference Citation Analysis]
143 Zeng F, Liu Y, Huang W, Qing H, Kadowaki T, Kashiwazaki H, Ni J, Wu Z. Receptor for advanced glycation end products up-regulation in cerebral endothelial cells mediates cerebrovascular-related amyloid β accumulation after Porphyromonas gingivalis infection. J Neurochem 2021;158:724-36. [PMID: 32441775 DOI: 10.1111/jnc.15096] [Reference Citation Analysis]
144 Hopkins RO. Acquired Brain Injury Following Sepsis. Crit Care Med 2019;47:1658-9. [PMID: 31609262 DOI: 10.1097/CCM.0000000000003981] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 Sarfo FS, Akinyemi R, Howard G, Howard VJ, Wahab K, Cushman M, Levine DA, Ogunniyi A, Unverzagt F, Owolabi M, Ovbiagele B. Vascular-brain Injury Progression after Stroke (VIPS) study: concept for understanding racial and geographic determinants of cognitive decline after stroke. J Neurol Sci 2020;412:116754. [PMID: 32120131 DOI: 10.1016/j.jns.2020.116754] [Reference Citation Analysis]
146 Tortajada-Soler M, Sánchez-Valdeón L, Blanco-Nistal M, Benítez-Andrades JA, Liébana-Presa C, Bayón-Darkistade E. Prevalence of Comorbidities in Individuals Diagnosed and Undiagnosed with Alzheimer's Disease in León, Spain and a Proposal for Contingency Procedures to Follow in the Case of Emergencies Involving People with Alzheimer's Disease. Int J Environ Res Public Health 2020;17:E3398. [PMID: 32414124 DOI: 10.3390/ijerph17103398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
147 Jazzar U, Shan Y, Klaassen Z, Freedland SJ, Kamat AM, Raji MA, Masel T, Tyler DS, Baillargeon J, Kuo YF, Mehta HB, Bergerot CD, Williams SB. Impact of Alzheimer's disease and related dementia diagnosis following treatment for bladder cancer. J Geriatr Oncol 2020;11:1118-24. [PMID: 32354675 DOI: 10.1016/j.jgo.2020.04.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
148 de Montgolfier O, Thorin-Trescases N, Thorin E. Pathological Continuum From the Rise in Pulse Pressure to Impaired Neurovascular Coupling and Cognitive Decline. Am J Hypertens 2020;33:375-90. [PMID: 32202623 DOI: 10.1093/ajh/hpaa001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
149 Das S, Zhang Z, Ang LC. Clinicopathological overlap of neurodegenerative diseases: A comprehensive review. J Clin Neurosci 2020;78:30-3. [PMID: 32354648 DOI: 10.1016/j.jocn.2020.04.088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
150 Derby CA. Trends in the public health significance, definitions of disease, and implications for prevention of Alzheimer’s disease. Curr Epidemiol Rep 2020;7:68-76. [DOI: 10.1007/s40471-020-00231-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
151 Lee NK, Kim H, Yang J, Kim J, Son JP, Jang H, Na DL. Heterogeneous Disease Progression in a Mouse Model of Vascular Cognitive Impairment. Int J Mol Sci 2020;21:E2820. [PMID: 32316637 DOI: 10.3390/ijms21082820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
152 Xu XD, Teng Y, Zou JY, Ye Y, Song H, Wang ZY. Effects of lycopene on vascular remodeling through the LXR-PI3K-AKT signaling pathway in APP/PS1 mice. Biochem Biophys Res Commun 2020;526:699-705. [PMID: 32253029 DOI: 10.1016/j.bbrc.2020.02.063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
153 Robert J, Button EB, Martin EM, McAlary L, Gidden Z, Gilmour M, Boyce G, Caffrey TM, Agbay A, Clark A, Silverman JM, Cashman NR, Wellington CL. Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E. Mol Neurodegener 2020;15:23. [PMID: 32213187 DOI: 10.1186/s13024-020-00366-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
154 Rivera-Rivera LA, Cody KA, Eisenmenger L, Cary P, Rowley HA, Carlsson CM, Johnson SC, Johnson KM. Assessment of vascular stiffness in the internal carotid artery proximal to the carotid canal in Alzheimer's disease using pulse wave velocity from low rank reconstructed 4D flow MRI. J Cereb Blood Flow Metab 2021;41:298-311. [PMID: 32169012 DOI: 10.1177/0271678X20910302] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
155 Xie B, Shi X, Xing Y, Tang Y. Association between atherosclerosis and Alzheimer's disease: A systematic review and meta-analysis. Brain Behav 2020;10:e01601. [PMID: 32162494 DOI: 10.1002/brb3.1601] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
156 Malek-Ahmadi M, Chen K, Perez SE, Mufson EJ. Cerebral Amyloid Angiopathy and Neuritic Plaque Pathology Correlate with Cognitive Decline in Elderly Non-Demented Individuals. J Alzheimers Dis 2019;67:411-22. [PMID: 30594928 DOI: 10.3233/JAD-180765] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
157 Semba RD, Tian Q, Carlson MC, Xue QL, Ferrucci L. Motoric cognitive risk syndrome: Integration of two early harbingers of dementia in older adults. Ageing Res Rev 2020;58:101022. [PMID: 31996326 DOI: 10.1016/j.arr.2020.101022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
158 Hayden EY, Huang JM, Charreton M, Nunez SM, Putman JN, Teter B, Lee JT, Welch A, Frautschy S, Cole G, Teng E, Hinman JD. Modeling Mixed Vascular and Alzheimer's Dementia Using Focal Subcortical Ischemic Stroke in Human ApoE4-TR:5XFAD Transgenic Mice. Transl Stroke Res 2020;11:1064-76. [PMID: 32086779 DOI: 10.1007/s12975-020-00786-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
159 Xia C, Vonder M, Sidorenkov G, Oudkerk M, de Groot JC, van der Harst P, de Bock GH, De Deyn PP, Vliegenthart R. The Relationship of Coronary Artery Calcium and Clinical Coronary Artery Disease with Cognitive Function: A Systematic Review and Meta-Analysis. J Atheroscler Thromb 2020;27:934-58. [PMID: 32062643 DOI: 10.5551/jat.52928] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
160 Rodriguez Then FS, Jackson J, Ware C, Churchyard R, Hanseeuw B; International Interdisciplinary Young Investigators Alzheimer’s & Dementia (https://iyialzheimer.wordpress.com/). Interdisciplinary and Transdisciplinary Perspectives: On the Road to a Holistic Approach to Dementia Prevention and Care. J Alzheimers Dis Rep 2020;4:39-48. [PMID: 32206756 DOI: 10.3233/ADR-180070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
161 Wiggins M, Arias F, Urman RD, Richman DC, Sweitzer BJ, Edwards AF, Armstrong MJ, Chopra A, Libon DJ, Price C. Common neurodegenerative disorders in the perioperative setting: Recommendations for screening from the Society for Perioperative Assessment and Quality Improvement (SPAQI). Perioper Care Oper Room Manag 2020;20:100092. [PMID: 32577538 DOI: 10.1016/j.pcorm.2020.100092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
162 Vu M, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Kettunen R, Hartikainen S, Tolppanen AM. Prevalence of cardiovascular drug use before and after diagnosis of Alzheimer's disease. Int J Cardiol 2020;300:221-5. [PMID: 31810814 DOI: 10.1016/j.ijcard.2019.09.036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
163 King CD, Robinson RAS. Evaluating Combined Precursor Isotopic Labeling and Isobaric Tagging Performance on Orbitraps To Study the Peripheral Proteome of Alzheimer's Disease. Anal Chem 2020;92:2911-6. [PMID: 31940168 DOI: 10.1021/acs.analchem.9b01974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
164 Rensma SP, van Sloten TT, Houben AJ, Köhler S, van Boxtel MP, Berendschot TT, Jansen JF, Verhey FR, Kroon AA, Koster A, Backes WH, Schaper N, Dinant G, Schalkwijk CG, Henry RM, Wolfs EM, van Heumen MJ, Schram MT, Stehouwer CD. Microvascular Dysfunction Is Associated With Worse Cognitive Performance: The Maastricht Study. Hypertension 2020;75:237-45. [DOI: 10.1161/hypertensionaha.119.13023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
165 Percy ME, Lukiw WJ. Is heart disease a risk factor for low dementia test battery scores in older persons with Down syndrome? Exploratory, pilot study, and commentary. Int J Dev Disabil 2020;66:22-35. [PMID: 33859818 DOI: 10.1080/20473869.2017.1301023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
166 Lim EY, Ryu SY, Shim YS, Yang DW, Cho AH. Coexistence of Cerebral Microbleeds and Amyloid Pathology in Patients with Cognitive Complaints. J Clin Neurol 2020;16:83-9. [PMID: 31942762 DOI: 10.3988/jcn.2020.16.1.83] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
167 Armstrong NM, Bangen KJ, Au R, Gross AL. Associations Between Midlife (but Not Late-Life) Elevated Coronary Heart Disease Risk and Lower Cognitive Performance: Results From the Framingham Offspring Study. Am J Epidemiol 2019;188:2175-87. [PMID: 31576397 DOI: 10.1093/aje/kwz210] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
168 Soldan A, Pettigrew C, Zhu Y, Wang MC, Moghekar A, Gottesman RF, Singh B, Martinez O, Fletcher E, DeCarli C, Albert M; BIOCARD Research Team. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease. Neurology 2020;94:e950-60. [PMID: 31888969 DOI: 10.1212/WNL.0000000000008864] [Cited by in Crossref: 15] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
169 Lobue C, Cullum CM. POINT/COUNTER-POINT—Beyond the headlines: the actual evidence that traumatic brain injury is a risk factor for later-in-life dementia. Archives of Clinical Neuropsychology 2020;35:123-7. [DOI: 10.1093/arclin/acz074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
170 Beishon LC, Batterham AP, Quinn TJ, Nelson CP, Panerai RB, Robinson T, Haunton VJ. Addenbrooke's Cognitive Examination III (ACE-III) and mini-ACE for the detection of dementia and mild cognitive impairment. Cochrane Database Syst Rev 2019;12:CD013282. [PMID: 31846066 DOI: 10.1002/14651858.CD013282.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
171 Garbarino S, Lorenzi M, Oxtoby NP, Vinke EJ, Marinescu RV, Eshaghi A, Ikram MA, Niessen WJ, Ciccarelli O, Barkhof F, Schott JM, Vernooij MW, Alexander DC; Alzheimer’s Disease Neuroimaging Initiative. Differences in topological progression profile among neurodegenerative diseases from imaging data. Elife 2019;8:e49298. [PMID: 31793876 DOI: 10.7554/eLife.49298] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
172 Li W, Li Y, Qiu Q, Sun L, Yue L, Li X, Xiao S. Associations Between the Apolipoprotein E ε4 Allele and Reduced Serum Levels of High Density Lipoprotein a Cognitively Normal Aging Han Chinese Population. Front Endocrinol (Lausanne) 2019;10:827. [PMID: 31866940 DOI: 10.3389/fendo.2019.00827] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
173 Jiang W, Hu CY, Li FL, Hua XG, Huang K, Zhang XJ. Elevated parathyroid hormone levels and cognitive function: A systematic review. Arch Gerontol Geriatr 2020;87:103985. [PMID: 31770681 DOI: 10.1016/j.archger.2019.103985] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
174 Soldan A, Pettigrew C, Albert M. Cognitive Reserve from the Perspective of Preclinical Alzheimer Disease: 2020 Update. Clin Geriatr Med 2020;36:247-63. [PMID: 32222300 DOI: 10.1016/j.cger.2019.11.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
175 Thal DR, Ronisz A, Tousseyn T, Rijal Upadhaya A, Balakrishnan K, Vandenberghe R, Vandenbulcke M, von Arnim CAF, Otto M, Beach TG, Lilja J, Heurling K, Chakrabarty A, Ismail A, Buckley C, Smith APL, Kumar S, Farrar G, Walter J. Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia. Acta Neuropathol Commun 2019;7:178. [PMID: 31727169 DOI: 10.1186/s40478-019-0837-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
176 Möllers T, Perna L, Stocker H, Ihle P, Schubert I, Schöttker B, Frölich L, Bauer J, Brenner H. Alzheimer's disease medication and outcomes of hospitalisation among patients with dementia. Epidemiol Psychiatr Sci 2019;29:e73. [PMID: 31722770 DOI: 10.1017/S2045796019000702] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
177 de Heus RA, Olde Rikkert MG, Tully PJ, Lawlor BA, Claassen JA; for the NILVAD Study Group. Blood Pressure Variability and Progression of Clinical Alzheimer Disease. Hypertension 2019;74:1172-80. [DOI: 10.1161/hypertensionaha.119.13664] [Cited by in Crossref: 27] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
178 Denver P, D'Adamo H, Hu S, Zuo X, Zhu C, Okuma C, Kim P, Castro D, Jones MR, Leal C, Mekkittikul M, Ghadishah E, Teter B, Vinters HV, Cole GM, Frautschy SA. A Novel Model of Mixed Vascular Dementia Incorporating Hypertension in a Rat Model of Alzheimer's Disease. Front Physiol 2019;10:1269. [PMID: 31708792 DOI: 10.3389/fphys.2019.01269] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
179 LoBue C, Woon FL, Rossetti HC, Hynan LS, Hart J, Cullum CM. Traumatic brain injury history and progression from mild cognitive impairment to Alzheimer disease. Neuropsychology 2018;32:401-9. [PMID: 29809031 DOI: 10.1037/neu0000431] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
180 Peters R, Ee N, Peters J, Beckett N, Booth A, Rockwood K, Anstey KJ. Common risk factors for major noncommunicable disease, a systematic overview of reviews and commentary: the implied potential for targeted risk reduction. Ther Adv Chronic Dis 2019;10:2040622319880392. [PMID: 31662837 DOI: 10.1177/2040622319880392] [Cited by in Crossref: 20] [Cited by in F6Publishing: 32] [Article Influence: 6.7] [Reference Citation Analysis]
181 Sharafi SM, Sylvestre JP, Chevrefils C, Soucy JP, Beaulieu S, Pascoal TA, Arbour JD, Rhéaume MA, Robillard A, Chayer C, Rosa-Neto P, Mathotaarachchi SS, Nasreddine ZS, Gauthier S, Lesage F. Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images. Alzheimers Dement (N Y) 2019;5:610-7. [PMID: 31650017 DOI: 10.1016/j.trci.2019.09.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
182 Verwer JH, Biessels GJ, Heinen R, Exalto LG, Emmelot-Vonk MH, Koek HL; Utrecht Vascular Cognitive Impairment (VCI) study group. Occurrence of Impaired Physical Performance in Memory Clinic Patients With Cerebral Small Vessel Disease. Alzheimer Dis Assoc Disord 2018;32:214-9. [PMID: 29240562 DOI: 10.1097/WAD.0000000000000233] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
183 Villabona-Rueda A, Erice C, Pardo CA, Stins MF. The Evolving Concept of the Blood Brain Barrier (BBB): From a Single Static Barrier to a Heterogeneous and Dynamic Relay Center. Front Cell Neurosci 2019;13:405. [PMID: 31616251 DOI: 10.3389/fncel.2019.00405] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 9.7] [Reference Citation Analysis]
184 Doig AJ. Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis. J Alzheimers Dis 2018;66:25-36. [PMID: 30282364 DOI: 10.3233/JAD-180583] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
185 Chong JSX, Jang H, Kim HJ, Ng KK, Na DL, Lee JH, Seo SW, Zhou J. Amyloid and cerebrovascular burden divergently influence brain functional network changes over time. Neurology 2019;93:e1514-25. [DOI: 10.1212/wnl.0000000000008315] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
186 Cho KH, Park HJ, Kim SJ, Kim JR. Decrease in HDL-C is Associated with Age and Household Income in Adults from the Korean National Health and Nutrition Examination Survey 2017: Correlation Analysis of Low HDL-C and Poverty. Int J Environ Res Public Health 2019;16:E3329. [PMID: 31509977 DOI: 10.3390/ijerph16183329] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
187 Marongiu R. Accelerated Ovarian Failure as a Unique Model to Study Peri-Menopause Influence on Alzheimer's Disease. Front Aging Neurosci 2019;11:242. [PMID: 31551757 DOI: 10.3389/fnagi.2019.00242] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
188 Tiel C, Sudo FK, Calmon AB. Neuropsychiatric symptoms and executive function impairments in Alzheimer's disease and vascular dementia: The role of subcortical circuits. Dement Neuropsychol 2019;13:293-8. [PMID: 31555401 DOI: 10.1590/1980-57642018dn13-030005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
189 Hampel H, O'Bryant SE, Molinuevo JL, Zetterberg H, Masters CL, Lista S, Kiddle SJ, Batrla R, Blennow K. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat Rev Neurol 2018;14:639-52. [PMID: 30297701 DOI: 10.1038/s41582-018-0079-7] [Cited by in Crossref: 194] [Cited by in F6Publishing: 252] [Article Influence: 64.7] [Reference Citation Analysis]
190 de la Torre J. The Vascular Hypothesis of Alzheimer's Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging. J Alzheimers Dis 2018;63:35-52. [PMID: 29614675 DOI: 10.3233/JAD-180004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 56] [Article Influence: 15.0] [Reference Citation Analysis]
191 Belloy ME, Napolioni V, Greicius MD. A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward. Neuron 2019;101:820-38. [PMID: 30844401 DOI: 10.1016/j.neuron.2019.01.056] [Cited by in Crossref: 125] [Cited by in F6Publishing: 171] [Article Influence: 41.7] [Reference Citation Analysis]
192 Cajavilca CE, Gadhia RR, Román GC. MTHFR Gene Mutations Correlate with White Matter Disease Burden and Predict Cerebrovascular Disease and Dementia. Brain Sci 2019;9:E211. [PMID: 31443445 DOI: 10.3390/brainsci9090211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
193 Hayden EY, Putman J, Nunez S, Shin WS, Oberoi M, Charreton M, Dutta S, Li Z, Komuro Y, Joy MT, Bitan G, MacKenzie-Graham A, Jiang L, Hinman JD. Ischemic axonal injury up-regulates MARK4 in cortical neurons and primes tau phosphorylation and aggregation. Acta Neuropathol Commun 2019;7:135. [PMID: 31429800 DOI: 10.1186/s40478-019-0783-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
194 Nasrallah IM, Pajewski NM, Auchus AP, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Doshi J, Erus G, Fine LJ, Gaussoin SA, Harris D, Johnson KC, Kimmel PL, Kurella Tamura M, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JT Jr, Wright CB, Williamson JD, Bryan RN; SPRINT MIND Investigators for the SPRINT Research Group. Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions. JAMA 2019;322:524-34. [PMID: 31408137 DOI: 10.1001/jama.2019.10551] [Cited by in Crossref: 157] [Cited by in F6Publishing: 139] [Article Influence: 52.3] [Reference Citation Analysis]
195 Matej R, Tesar A, Rusina R. Alzheimer's disease and other neurodegenerative dementias in comorbidity: A clinical and neuropathological overview. Clin Biochem 2019;73:26-31. [PMID: 31400306 DOI: 10.1016/j.clinbiochem.2019.08.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 39] [Article Influence: 8.7] [Reference Citation Analysis]
196 Bos I, Vos SJB, Schindler SE, Hassenstab J, Xiong C, Grant E, Verhey F, Morris JC, Visser PJ, Fagan AM. Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease. Alzheimers Dement 2019;15:1149-59. [PMID: 31378575 DOI: 10.1016/j.jalz.2019.04.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
197 Sundaresan V, Zamboni G, Le Heron C, Rothwell PM, Husain M, Battaglini M, De Stefano N, Jenkinson M, Griffanti L. Automated lesion segmentation with BIANCA: Impact of population-level features, classification algorithm and locally adaptive thresholding. Neuroimage 2019;202:116056. [PMID: 31376518 DOI: 10.1016/j.neuroimage.2019.116056] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
198 Thyrian JR, Hertel J, Schulze LN, Dörr M, Prüss H, Hempel P, Bimmler M, Kunze R, Grabe HJ, Teipel S, Hoffmann W. Prevalence and Determinants of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients Screened Positive for Dementia: Results from the Population-Based DelpHi-Study. J Alzheimers Dis 2018;64:1091-7. [PMID: 30010118 DOI: 10.3233/JAD-171096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
199 Le Heron C, Manohar S, Plant O, Muhammed K, Griffanti L, Nemeth A, Douaud G, Markus HS, Husain M. Dysfunctional effort-based decision-making underlies apathy in genetic cerebral small vessel disease. Brain 2018;141:3193-210. [PMID: 30346491 DOI: 10.1093/brain/awy257] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
200 Paraskevas GP, Constantinides VC, Pyrgelis ES, Kapaki E. Mixed Small Vessel Disease in a Patient with Dementia with Lewy Bodies. Brain Sci 2019;9:E159. [PMID: 31277472 DOI: 10.3390/brainsci9070159] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
201 Xu X, Phua A, Collinson SL, Hilal S, Ikram MK, Wong TY, Cheng CY, Venketasubramanian N, Chen C. Additive effect of cerebral atrophy on cognition in dementia-free elderly with cerebrovascular disease. Stroke Vasc Neurol 2019;4:135-40. [PMID: 31709119 DOI: 10.1136/svn-2018-000202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
202 Bogorad MI, DeStefano JG, Linville RM, Wong AD, Searson PC. Cerebrovascular plasticity: Processes that lead to changes in the architecture of brain microvessels. J Cereb Blood Flow Metab 2019;39:1413-32. [PMID: 31208241 DOI: 10.1177/0271678X19855875] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
203 Cherbuin N, Shaw ME, Walsh E, Sachdev P, Anstey KJ. Validated Alzheimer's Disease Risk Index (ANU-ADRI) is associated with smaller volumes in the default mode network in the early 60s. Brain Imaging Behav 2019;13:65-74. [PMID: 29243120 DOI: 10.1007/s11682-017-9789-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
204 San Segundo-Acosta P, Montero-Calle A, Fuentes M, Rábano A, Villalba M, Barderas R. Identification of Alzheimer's Disease Autoantibodies and Their Target Biomarkers by Phage Microarrays. J Proteome Res 2019;18:2940-53. [PMID: 31136180 DOI: 10.1021/acs.jproteome.9b00258] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
205 Han H, Hou Y, Hsu S. Angiogenic potential of co-spheroids of neural stem cells and endothelial cells in injectable gelatin-based hydrogel. Materials Science and Engineering: C 2019;99:140-9. [DOI: 10.1016/j.msec.2019.01.089] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
206 Kamara DM, Gangishetti U, Gearing M, Willis-Parker M, Zhao L, Hu WT, Walker LC. Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 2018;62:1815-26. [PMID: 29614657 DOI: 10.3233/JAD-170954] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
207 Verwer JH, Reijmer YD, Koek HL, Biessels GJ; Utrecht Vascular Cognitive Impairment (VCI) Study Group. Physical Performance in Memory Clinic Patients: The Potential Role of the White Matter Network. J Am Geriatr Soc 2019;67:1880-7. [PMID: 31135061 DOI: 10.1111/jgs.15987] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
208 Wallin A, Román GC, Esiri M, Kettunen P, Svensson J, Paraskevas GP, Kapaki E. Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease. J Alzheimers Dis 2018;62:1417-41. [PMID: 29562536 DOI: 10.3233/JAD-170803] [Cited by in Crossref: 47] [Cited by in F6Publishing: 55] [Article Influence: 15.7] [Reference Citation Analysis]
209 Button EB, Boyce GK, Wilkinson A, Stukas S, Hayat A, Fan J, Wadsworth BJ, Robert J, Martens KM, Wellington CL. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice. Alzheimers Res Ther 2019;11:44. [PMID: 31084613 DOI: 10.1186/s13195-019-0497-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
210 Wu A, Sharrett AR, Gottesman RF, Power MC, Mosley TH Jr, Jack CR Jr, Knopman DS, Windham BG, Gross AL, Coresh J. Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment. JAMA Netw Open 2019;2:e193359. [PMID: 31074810 DOI: 10.1001/jamanetworkopen.2019.3359] [Cited by in Crossref: 16] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
211 Basit S, Wohlfahrt J, Boyd HA. Pregnancy loss and risk of later dementia: A nationwide cohort study, Denmark, 1977-2017. Alzheimers Dement (N Y) 2019;5:146-53. [PMID: 31065584 DOI: 10.1016/j.trci.2019.02.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
212 Boumenir A, Cognat E, Sabia S, Hourregue C, Lilamand M, Dugravot A, Bouaziz-Amar E, Laplanche JL, Hugon J, Singh-Manoux A, Paquet C, Dumurgier J. CSF level of β-amyloid peptide predicts mortality in Alzheimer's disease. Alzheimers Res Ther 2019;11:29. [PMID: 30922415 DOI: 10.1186/s13195-019-0481-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
213 Feinkohl I, Janke J, Hadzidiakos D, Slooter A, Winterer G, Spies C, Pischon T. Associations of the metabolic syndrome and its components with cognitive impairment in older adults. BMC Geriatr 2019;19:77. [PMID: 30845934 DOI: 10.1186/s12877-019-1073-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
214 Kim JW, Byun MS, Yi D, Lee JH, Ko K, Jung G, Lee DY. Vascular risk modulates the relationship between cerebral amyloid deposition and subjective memory complaints. Neuropsychiatr Dis Treat 2019;15:637-45. [PMID: 30880988 DOI: 10.2147/NDT.S192231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
215 Ouanes S, Popp J. High Cortisol and the Risk of Dementia and Alzheimer's Disease: A Review of the Literature. Front Aging Neurosci 2019;11:43. [PMID: 30881301 DOI: 10.3389/fnagi.2019.00043] [Cited by in Crossref: 75] [Cited by in F6Publishing: 104] [Article Influence: 25.0] [Reference Citation Analysis]
216 Reynolds DS. A short perspective on the long road to effective treatments for Alzheimer's disease. Br J Pharmacol 2019;176:3636-48. [PMID: 30657599 DOI: 10.1111/bph.14581] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
217 Jonkman LE, Kenkhuis B, Geurts JJG, van de Berg WDJ. Post-Mortem MRI and Histopathology in Neurologic Disease: A Translational Approach. Neurosci Bull 2019;35:229-43. [PMID: 30790214 DOI: 10.1007/s12264-019-00342-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
218 Park KM, Sung JM, Kim WJ, An SK, Namkoong K, Lee E, Chang HJ. Population-based dementia prediction model using Korean public health examination data: A cohort study. PLoS One 2019;14:e0211957. [PMID: 30753205 DOI: 10.1371/journal.pone.0211957] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
219 Broce IJ, Tan CH, Fan CC, Jansen I, Savage JE, Witoelar A, Wen N, Hess CP, Dillon WP, Glastonbury CM, Glymour M, Yokoyama JS, Elahi FM, Rabinovici GD, Miller BL, Mormino EC, Sperling RA, Bennett DA, McEvoy LK, Brewer JB, Feldman HH, Hyman BT, Pericak-Vance M, Haines JL, Farrer LA, Mayeux R, Schellenberg GD, Yaffe K, Sugrue LP, Dale AM, Posthuma D, Andreassen OA, Karch CM, Desikan RS. Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease. Acta Neuropathol 2019;137:209-26. [PMID: 30413934 DOI: 10.1007/s00401-018-1928-6] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 19.7] [Reference Citation Analysis]
220 Van Giau V, An SSA. Epitope Mapping Immunoassay Analysis of the Interaction between β-Amyloid and Fibrinogen. Int J Mol Sci 2019;20:E496. [PMID: 30678343 DOI: 10.3390/ijms20030496] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
221 Button EB, Gilmour M, Cheema HK, Martin EM, Agbay A, Robert J, Wellington CL. Vasoprotective Functions of High-Density Lipoproteins Relevant to Alzheimer's Disease Are Partially Conserved in Apolipoprotein B-Depleted Plasma. Int J Mol Sci 2019;20:E462. [PMID: 30678190 DOI: 10.3390/ijms20030462] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
222 Yin JH, Tsai CL, Lee PJ, Chou CH, Chen SY, Chung CH, Chien WC, Lin CC, Sung YF, Yang FC, Tsai CK, Lee JT. Age-specific and gender-dependent impact of primary headache disorders on dementia risk: Population-based longitudinal study. Medicine (Baltimore) 2018;97:e13789. [PMID: 30593163 DOI: 10.1097/MD.0000000000013789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
223 Dobrynina LA, Gadzhieva ZS, Akhmetzyanov BM, Kalashnikova LA, Krotenkova MV. [The role of arterial, venous blood and cerebrospinal fluid flow disturbances in forming cognitive impairment types in age-related cerebral microangiophathy]. Zh Nevrol Psikhiatr Im S S Korsakova 2019;119:81-8. [PMID: 32207722 DOI: 10.17116/jnevro201911912281] [Reference Citation Analysis]
224 Vecchio LM, Meng Y, Xhima K, Lipsman N, Hamani C, Aubert I. The Neuroprotective Effects of Exercise: Maintaining a Healthy Brain Throughout Aging. Brain Plast 2018;4:17-52. [PMID: 30564545 DOI: 10.3233/BPL-180069] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 10.3] [Reference Citation Analysis]
225 Rodrigues LL, Mesquita LP, Costa RC, Gomes RG, Biihrer DA, Maiorka PC. Multiple infarcts and hemorrhages in the central nervous system of a dog with cerebral amyloid angiopathy: a case report. BMC Vet Res 2018;14:370. [PMID: 30482198 DOI: 10.1186/s12917-018-1700-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
226 Kizil C, Bhattarai P. Is Alzheimer's Also a Stem Cell Disease? - The Zebrafish Perspective. Front Cell Dev Biol 2018;6:159. [PMID: 30533414 DOI: 10.3389/fcell.2018.00159] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
227 Khoradmehr A, Mazaheri F, Anvari M, Tamadon A. A Simple Technique for Three-Dimensional Imaging and Segmentation of Brain Vasculature U sing Fast Free-of-Acrylamide Clearing Tissue in Murine. Cell J 2019;21:49-56. [PMID: 30507088 DOI: 10.22074/cellj.2019.5684] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
228 Liyanage SI, Santos C, Weaver DF. The hidden variables problem in Alzheimer's disease clinical trial design. Alzheimers Dement (N Y) 2018;4:628-35. [PMID: 30519628 DOI: 10.1016/j.trci.2018.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
229 Elahi FM, Casaletto KB, Altendahl M, Staffaroni AM, Fletcher E, Filshtein TJ, Glymour MM, Miller BL, Hinman JD, DeCarli C, Goetzl EJ, Kramer JH. "Liquid Biopsy" of White Matter Hyperintensity in Functionally Normal Elders. Front Aging Neurosci 2018;10:343. [PMID: 30483114 DOI: 10.3389/fnagi.2018.00343] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
230 Assaf G, Tanielian M. Mild cognitive impairment in primary care: a clinical review. Postgrad Med J 2019;94:647-52. [DOI: 10.1136/postgradmedj-2018-136035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
231 Jandke S, Garz C, Schwanke D, Sendtner M, Heinze HJ, Carare RO, Schreiber S. The association between hypertensive arteriopathy and cerebral amyloid angiopathy in spontaneously hypertensive stroke-prone rats. Brain Pathol 2018;28:844-59. [PMID: 30062722 DOI: 10.1111/bpa.12629] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
232 Wang R, Laveskog A, Laukka EJ, Kalpouzos G, Bäckman L, Fratiglioni L, Qiu C. MRI load of cerebral microvascular lesions and neurodegeneration, cognitive decline, and dementia. Neurology 2018;91:e1487-97. [PMID: 30232255 DOI: 10.1212/WNL.0000000000006355] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
233 Brickman AM, Tosto G, Gutierrez J, Andrews H, Gu Y, Narkhede A, Rizvi B, Guzman V, Manly JJ, Vonsattel JP, Schupf N, Mayeux R. An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease. Neurology 2018;91:e1402-12. [PMID: 30217936 DOI: 10.1212/WNL.0000000000006310] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
234 Di Giovanna AP, Tibo A, Silvestri L, Müllenbroich MC, Costantini I, Allegra Mascaro AL, Sacconi L, Frasconi P, Pavone FS. Whole-Brain Vasculature Reconstruction at the Single Capillary Level. Sci Rep 2018;8:12573. [PMID: 30135559 DOI: 10.1038/s41598-018-30533-3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 12.0] [Reference Citation Analysis]
235 Jang JW, Park JH, Kim S, Park YH, Pyun JM, Lim JS, Kim Y, Youn YC, Kim S; Alzheimer’s Disease Neuroimaging Initiative. A 'Comprehensive Visual Rating Scale' for predicting progression to dementia in patients with mild cognitive impairment. PLoS One 2018;13:e0201852. [PMID: 30125290 DOI: 10.1371/journal.pone.0201852] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
236 Kim JH, Chon D. Association between Cognitive Impairment, Vascular Disease and All-Cause Mortality. J Nutr Health Aging 2018;22:790-5. [PMID: 30080221 DOI: 10.1007/s12603-018-1011-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
237 Ursin MH, Bergland A, Fure B, Thommessen B, Hagberg G, Øksengård AR, Ihle-Hansen H. Gait and balance one year after stroke; relationships with lesion side, subtypes of cognitive impairment and neuroimaging findings-a longitudinal, cohort study. Physiotherapy 2019;105:254-61. [PMID: 30340837 DOI: 10.1016/j.physio.2018.07.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
238 Paradise MB, Shepherd CE, Wen W, Sachdev PS. Neuroimaging and neuropathology indices of cerebrovascular disease burden: A systematic review. Neurology 2018;91:310-20. [DOI: 10.1212/wnl.0000000000005997] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
239 Li Y, Choi WJ, Wei W, Song S, Zhang Q, Liu J, Wang RK. Aging-associated changes in cerebral vasculature and blood flow as determined by quantitative optical coherence tomography angiography. Neurobiol Aging 2018;70:148-59. [PMID: 30007164 DOI: 10.1016/j.neurobiolaging.2018.06.017] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 9.5] [Reference Citation Analysis]
240 Cheng CK, Tsao YC, Su YC, Sung FC, Tai HC, Kung WM. Metabolic Risk Factors of Alzheimer's Disease, Dementia with Lewy Bodies, and Normal Elderly: A Population-Based Study. Behav Neurol 2018;2018:8312346. [PMID: 29971140 DOI: 10.1155/2018/8312346] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
241 Owolabi M, Ojagbemi A, Kalaria R, Sarfo FS, Akinyemi R. Behavioural and Cognitive Effects of Cerebrovascular Diseases. Behav Neurol 2018;2018:7516032. [PMID: 29849814 DOI: 10.1155/2018/7516032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
242 Saeed U, Mirza SS, MacIntosh BJ, Herrmann N, Keith J, Ramirez J, Nestor SM, Yu Q, Knight J, Swardfager W, Potkin SG, Rogaeva E, St George-Hyslop P, Black SE, Masellis M. APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies. Alzheimers Dement 2018;14:1137-47. [PMID: 29782824 DOI: 10.1016/j.jalz.2018.04.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
243 Xu X, Lau KK, Wong YK, Mak HKF, Hui ES. The effect of the total small vessel disease burden on the structural brain network. Sci Rep 2018;8:7442. [PMID: 29748646 DOI: 10.1038/s41598-018-25917-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
244 Claus JJ, Coenen M, Staekenborg SS, Schuur J, Tielkes CE, Koster P, Scheltens P. Cerebral White Matter Lesions have Low Impact on Cognitive Function in a Large Elderly Memory Clinic Population. JAD 2018;63:1129-39. [DOI: 10.3233/jad-171111] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
245 Ruthirakuhan MT, Herrmann N, Abraham EH, Chan S, Lanctôt KL. Pharmacological interventions for apathy in Alzheimer's disease. Cochrane Database Syst Rev 2018;5:CD012197. [PMID: 29727467 DOI: 10.1002/14651858.CD012197.pub2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
246 Palesi F, De Rinaldis A, Vitali P, Castellazzi G, Casiraghi L, Germani G, Bernini S, Anzalone N, Ramusino MC, Denaro FM, Sinforiani E, Costa A, Magenes G, D'Angelo E, Gandini Wheeler-Kingshott CAM, Micieli G. Specific Patterns of White Matter Alterations Help Distinguishing Alzheimer's and Vascular Dementia. Front Neurosci 2018;12:274. [PMID: 29922120 DOI: 10.3389/fnins.2018.00274] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
247 Vinters HV, Zarow C, Borys E, Whitman JD, Tung S, Ellis WG, Zheng L, Chui HC. Review: Vascular dementia: clinicopathologic and genetic considerations. Neuropathol Appl Neurobiol 2018;44:247-66. [DOI: 10.1111/nan.12472] [Cited by in Crossref: 34] [Cited by in F6Publishing: 41] [Article Influence: 8.5] [Reference Citation Analysis]
248 Coughlan G, Flanagan E, Jeffs S, Bertoux M, Spiers H, Mioshi E, Hornberger M. Diagnostic relevance of spatial orientation for vascular dementia: A case study. Dement Neuropsychol 2018;12:85-91. [PMID: 29682239 DOI: 10.1590/1980-57642018dn12-010013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
249 Koncz R, Sachdev PS. Are the brain's vascular and Alzheimer pathologies additive or interactive? Current Opinion in Psychiatry 2018;31:147-52. [DOI: 10.1097/yco.0000000000000395] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
250 Heuer E, Jacobs J, Du R, Wang S, Keifer OP, Cintron AF, Dooyema J, Meng Y, Zhang X, Walker LC. Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy. J Alzheimers Dis 2017;57:519-30. [PMID: 28269776 DOI: 10.3233/JAD-160981] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
251 Freeze WM, Jacobs HI, Gronenschild EH, Jansen JF, Burgmans S, Aalten P, Clerx L, Vos SJ, van Buchem MA, Barkhof F, van der Flier WM, Verbeek MM, Rikkert MO, Backes WH, Verhey FR; LeARN project. White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β. J Alzheimers Dis 2017;55:333-42. [PMID: 27662299 DOI: 10.3233/JAD-160474] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
252 Xiao LY, Wang XR, Yang JW, Ye Y, Zhu W, Cao Y, Ma SM, Liu CZ. Acupuncture Prevents the Impairment of Hippocampal LTP Through β1-AR in Vascular Dementia Rats. Mol Neurobiol 2018;55:7677-90. [PMID: 29435917 DOI: 10.1007/s12035-018-0943-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
253 Xu Q, Shan C, Wang Y, Shi Y, Zhang Q, Zheng G, Chang RC. Chinese Herbal Medicine for Vascular Dementia: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials. JAD 2018;62:429-56. [DOI: 10.3233/jad-170856] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
254 Skrobot OA, McKnight AJ, Passmore PA, Seripa D, Mecocci P, Panza F, Kalaria R, Wilcock G, Munafò M, Erkinjuntti T, Karhunen P, Pessi T, Martiskainen M, Love S, Kehoe PG; Genetic and Environmental Risk for Alzheimer’s disease Consortium (GERAD1). A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative Cohort. J Alzheimers Dis 2016;53:981-9. [PMID: 27314523 DOI: 10.3233/JAD-150862] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
255 Swardfager W, Cogo-Moreira H, Masellis M, Ramirez J, Herrmann N, Edwards JD, Saleem M, Chan P, Yu D, Nestor SM, Scott CJM, Holmes MF, Sahlas DJ, Kiss A, Oh PI, Strother SC, Gao F, Stefanovic B, Keith J, Symons S, Swartz RH, Lanctôt KL, Stuss DT, Black SE. The effect of white matter hyperintensities on verbal memory: Mediation by temporal lobe atrophy. Neurology 2018;90:e673-82. [PMID: 29374101 DOI: 10.1212/WNL.0000000000004983] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
256 Georgakis MK, Chatzopoulou D, Tsivgoulis G, Petridou ET. Albuminuria and Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis. J Am Geriatr Soc 2018;66:509-17. [PMID: 29372928 DOI: 10.1111/jgs.15240] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
257 Wijesinghe P, Shankar SK, Yasha TC, Gorrie C, Amaratunga D, Hulathduwa S, Kumara KS, Samarasinghe K, Suh YH, Steinbusch HW, De Silva KR. Vascular Contributions in Alzheimer's Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population. J Alzheimers Dis 2016;54:1607-18. [PMID: 27589527 DOI: 10.3233/JAD-160425] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
258 Zhu Y, Hilal S, Chai YL, Ikram MK, Venketasubramanian N, Chen CP, Lai MKP. Serum Hepatocyte Growth Factor Is Associated with Small Vessel Disease in Alzheimer's Dementia. Front Aging Neurosci 2018;10:8. [PMID: 29410622 DOI: 10.3389/fnagi.2018.00008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
259 Bennett RE, Robbins AB, Hu M, Cao X, Betensky RA, Clark T, Das S, Hyman BT. Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease. Proc Natl Acad Sci U S A 2018;115:E1289-98. [PMID: 29358399 DOI: 10.1073/pnas.1710329115] [Cited by in Crossref: 100] [Cited by in F6Publishing: 119] [Article Influence: 25.0] [Reference Citation Analysis]
260 Umlauf E, Rappold E, Schiller B, Fuchs P, Rainer M, Wolf B, Zellner M. Careful neuropsychological testing reveals a novel genetic marker, GSTO1*C, linked to the pre-stage of Alzheimer's disease. Oncotarget 2016;7:39108-17. [PMID: 27259244 DOI: 10.18632/oncotarget.9773] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
261 Bos I, Verhey FR, Ramakers IHGB, Jacobs HIL, Soininen H, Freund-Levi Y, Hampel H, Tsolaki M, Wallin ÅK, van Buchem MA, Oleksik A, Verbeek MM, Olde Rikkert M, van der Flier WM, Scheltens P, Aalten P, Visser PJ, Vos SJB. Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline. Alzheimers Res Ther 2017;9:101. [PMID: 29284531 DOI: 10.1186/s13195-017-0328-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
262 Decker Y, Müller A, Németh E, Schulz-schaeffer WJ, Fatar M, Menger MD, Liu Y, Fassbender K. Analysis of the vasculature by immunohistochemistry in paraffin-embedded brains. Brain Struct Funct 2018;223:1001-15. [DOI: 10.1007/s00429-017-1595-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
263 Ottoy J, Verhaeghe J, Niemantsverdriet E, Engelborghs S, Stroobants S, Staelens S. A simulation study on the impact of the blood flow-dependent component in [18F]AV45 SUVR in Alzheimer's disease. PLoS One 2017;12:e0189155. [PMID: 29211812 DOI: 10.1371/journal.pone.0189155] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
264 Holz MR, Kochhann R, Ferreira P, Tarrasconi M, Chaves MLF, Fonseca RP. Cognitive performance in patients with Mild Cognitive Impairment and Alzheimer's disease with white matter hyperintensities: An exploratory analysis. Dement Neuropsychol 2017;11:426-33. [PMID: 29354224 DOI: 10.1590/1980-57642016dn11-040013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
265 Corriveau RA, Koroshetz WJ, Gladman JT, Jeon S, Babcock D, Bennett DA, Carmichael ST, Dickinson SL, Dickson DW, Emr M, Fillit H, Greenberg SM, Hutton ML, Knopman DS, Manly JJ, Marder KS, Moy CS, Phelps CH, Scott PA, Seeley WW, Sieber BA, Silverberg NB, Sutherland ML, Taylor A, Torborg CL, Waddy SP, Gubitz AK, Holtzman DM. Alzheimer's Disease-Related Dementias Summit 2016: National research priorities. Neurology 2017;89:2381-91. [PMID: 29117955 DOI: 10.1212/WNL.0000000000004717] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 11.8] [Reference Citation Analysis]
266 Chong JSX, Liu S, Loke YM, Hilal S, Ikram MK, Xu X, Tan BY, Venketasubramanian N, Chen CL, Zhou J. Influence of cerebrovascular disease on brain networks in prodromal and clinical Alzheimer's disease. Brain 2017;140:3012-22. [PMID: 29053778 DOI: 10.1093/brain/awx224] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
267 Robert J, Button EB, Yuen B, Gilmour M, Kang K, Bahrabadi A, Stukas S, Zhao W, Kulic I, Wellington CL. Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels. Elife 2017;6:e29595. [PMID: 28994390 DOI: 10.7554/eLife.29595] [Cited by in Crossref: 47] [Cited by in F6Publishing: 59] [Article Influence: 9.4] [Reference Citation Analysis]
268 Evans NR, Tarkin JM, Buscombe JR, Markus HS, Rudd JHF, Warburton EA. PET imaging of the neurovascular interface in cerebrovascular disease. Nat Rev Neurol 2017;13:676-88. [PMID: 28984315 DOI: 10.1038/nrneurol.2017.129] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
269 Guglielmotto M, Monteleone D, Vasciaveo V, Repetto IE, Manassero G, Tabaton M, Tamagno E. The Decrease of Uch-L1 Activity Is a Common Mechanism Responsible for Aβ 42 Accumulation in Alzheimer's and Vascular Disease. Front Aging Neurosci 2017;9:320. [PMID: 29033830 DOI: 10.3389/fnagi.2017.00320] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
270 Chung C, Lee H, Lin P, Wang P, Salmerón S. Cerebral Artery Pulsatility is Associated with Cognitive Impairment and Predicts Dementia in Individuals with Subjective Memory Decline or Mild Cognitive Impairment. JAD 2017;60:625-32. [DOI: 10.3233/jad-170349] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
271 Roussotte FF, Siddarth P, Merrill DA, Narr KL, Ercoli LM, Martinez J, Emerson ND, Barrio JR, Small GW. In Vivo Brain Plaque and Tangle Burden Mediates the Association Between Diastolic Blood Pressure and Cognitive Functioning in Nondemented Adults. Am J Geriatr Psychiatry 2018;26:13-22. [PMID: 29111133 DOI: 10.1016/j.jagp.2017.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
272 Tariq S, Barber PA. Dementia risk and prevention by targeting modifiable vascular risk factors. J Neurochem 2018;144:565-81. [PMID: 28734089 DOI: 10.1111/jnc.14132] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
273 Lai AY, McLaurin J. Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease. J Neurochem 2018;144:659-68. [PMID: 28722749 DOI: 10.1111/jnc.14130] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
274 Ji F, Pasternak O, Liu S, Loke YM, Choo BL, Hilal S, Xu X, Ikram MK, Venketasubramanian N, Chen CL, Zhou J. Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease. Alzheimers Res Ther 2017;9:63. [PMID: 28818116 DOI: 10.1186/s13195-017-0292-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
275 Tayler HM, Palmer JC, Thomas TL, Kehoe PG, Paton JF, Love S. Cerebral Aβ40 and systemic hypertension. J Cereb Blood Flow Metab 2018;38:1993-2005. [PMID: 28782443 DOI: 10.1177/0271678X17724930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
276 Attems J. The multi-morbid old brain. Acta Neuropathol 2017;134:169-70. [PMID: 28509946 DOI: 10.1007/s00401-017-1723-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
277 Kapasi A, DeCarli C, Schneider JA. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol 2017;134:171-86. [PMID: 28488154 DOI: 10.1007/s00401-017-1717-7] [Cited by in Crossref: 300] [Cited by in F6Publishing: 258] [Article Influence: 60.0] [Reference Citation Analysis]
278 Kelly P, Denver P, Satchell SC, Ackermann M, Konerding MA, Mitchell CA. Microvascular ultrastructural changes precede cognitive impairment in the murine APPswe/PS1dE9 model of Alzheimer's disease. Angiogenesis 2017;20:567-80. [PMID: 28741167 DOI: 10.1007/s10456-017-9568-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
279 Glushakova OY, Glushakov AA, Wijesinghe DS, Valadka AB, Hayes RL, Glushakov AV. Prospective clinical biomarkers of caspase-mediated apoptosis associated with neuronal and neurovascular damage following stroke and other severe brain injuries: Implications for chronic neurodegeneration. Brain Circ 2017;3:87-108. [PMID: 30276309 DOI: 10.4103/bc.bc_27_16] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
280 Callisaya M, Nosaka K. Effects of Exercise on Type 2 Diabetes Mellitus-Related Cognitive Impairment and Dementia. JAD 2017;59:503-13. [DOI: 10.3233/jad-161154] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
281 Hefter D, Kaiser M, Weyer SW, Papageorgiou IE, Both M, Kann O, Müller UC, Draguhn A. Amyloid Precursor Protein Protects Neuronal Network Function after Hypoxia via Control of Voltage-Gated Calcium Channels. J Neurosci 2016;36:8356-71. [PMID: 27511009 DOI: 10.1523/JNEUROSCI.4130-15.2016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
282 Skillbäck T, Delsing L, Synnergren J, Mattsson N, Janelidze S, Nägga K, Kilander L, Hicks R, Wimo A, Winblad B, Hansson O, Blennow K, Eriksdotter M, Zetterberg H. CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients. Neurobiol Aging 2017;59:1-9. [PMID: 28779628 DOI: 10.1016/j.neurobiolaging.2017.06.028] [Cited by in Crossref: 41] [Cited by in F6Publishing: 49] [Article Influence: 8.2] [Reference Citation Analysis]
283 Levit A, Regis AM, Garabon JR, Oh SH, Desai SJ, Rajakumar N, Hachinski V, Agca Y, Agca C, Whitehead SN, Allman BL. Behavioural inflexibility in a comorbid rat model of striatal ischemic injury and mutant hAPP overexpression. Behav Brain Res 2017;333:267-75. [PMID: 28693862 DOI: 10.1016/j.bbr.2017.07.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
284 Tosto G, Bird TD, Bennett DA, Boeve BF, Brickman AM, Cruchaga C, Faber K, Foroud TM, Farlow M, Goate AM, Graff-Radford NR, Lantigua R, Manly J, Ottman R, Rosenberg R, Schaid DJ, Schupf N, Stern Y, Sweet RA, Mayeux R; National Institute on Aging Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) Family Study Group. The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease. JAMA Neurol 2016;73:1231-7. [PMID: 27533593 DOI: 10.1001/jamaneurol.2016.2539] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
285 Boyce G, Button E, Soo S, Wellington C. The pleiotropic vasoprotective functions of high density lipoproteins (HDL). J Biomed Res 2017. [PMID: 28550271 DOI: 10.7555/JBR.31.20160103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
286 Macpherson H, Teo WP, Schneider LA, Smith AE. A Life-Long Approach to Physical Activity for Brain Health. Front Aging Neurosci 2017;9:147. [PMID: 28588474 DOI: 10.3389/fnagi.2017.00147] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
287 Mullins RJ, Diehl TC, Chia CW, Kapogiannis D. Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease. Front Aging Neurosci 2017;9:118. [PMID: 28515688 DOI: 10.3389/fnagi.2017.00118] [Cited by in Crossref: 59] [Cited by in F6Publishing: 69] [Article Influence: 11.8] [Reference Citation Analysis]
288 Millan MJ. Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: An integrative review. Prog Neurobiol 2017;156:1-68. [PMID: 28322921 DOI: 10.1016/j.pneurobio.2017.03.004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 76] [Article Influence: 13.4] [Reference Citation Analysis]
289 Coutu JP, Lindemer ER, Konukoglu E, Salat DH; Alzheimer's Disease Neuroimaging Initiative (ADNI). Two distinct classes of degenerative change are independently linked to clinical progression in mild cognitive impairment. Neurobiol Aging 2017;54:1-9. [PMID: 28286328 DOI: 10.1016/j.neurobiolaging.2017.02.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
290 Yang C, Huang X, Huang X, Mai H, Li J, Jiang T, Wang X, Lü T. Aquaporin-4 and Alzheimer's Disease. J Alzheimers Dis 2016;52:391-402. [PMID: 27031475 DOI: 10.3233/JAD-150949] [Cited by in Crossref: 18] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
291 Mamelak M. Energy and the Alzheimer brain. Neurosci Biobehav Rev 2017;75:297-313. [PMID: 28193453 DOI: 10.1016/j.neubiorev.2017.02.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
292 Chai YL, Hilal S, Chong JP, Ng YX, Liew OW, Xu X, Ikram MK, Venketasubramanian N, Richards AM, Lai MK, Chen CP. Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia. Medicine (Baltimore). 2016;95:e4566. [PMID: 27537582 DOI: 10.1097/md.0000000000004566] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
293 Georgakis MK, Dimitriou NG, Karalexi MA, Mihas C, Nasothimiou EG, Tousoulis D, Tsivgoulis G, Petridou ET. Albuminuria in Association with Cognitive Function and Dementia: A Systematic Review and Meta-Analysis. J Am Geriatr Soc 2017;65:1190-8. [PMID: 28152169 DOI: 10.1111/jgs.14750] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
294 Hefter D, Draguhn A. APP as a Protective Factor in Acute Neuronal Insults. Front Mol Neurosci 2017;10:22. [PMID: 28210211 DOI: 10.3389/fnmol.2017.00022] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
295 Macklin L, Griffith CM, Cai Y, Rose GM, Yan X, Patrylo PR. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline. Experimental Gerontology 2017;88:9-18. [DOI: 10.1016/j.exger.2016.12.019] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 7.4] [Reference Citation Analysis]
296 Giacomelli C, Daniele S, Martini C. Potential biomarkers and novel pharmacological targets in protein aggregation-related neurodegenerative diseases. Biochem Pharmacol 2017;131:1-15. [PMID: 28159621 DOI: 10.1016/j.bcp.2017.01.017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
297 Slot RE, Van Harten AC, Kester MI, Jongbloed W, Bouwman FH, Teunissen CE, Scheltens P, Veerhuis R, van der Flier WM, Darreh-shori T. Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer’s Disease in Non-Demented Elderly. JAD 2017;56:687-97. [DOI: 10.3233/jad-151068] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
298 Zhu Y, Chai YL, Hilal S, Ikram MK, Venketasubramanian N, Wong BS, Chen CP, Lai MK. Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease. Alzheimers Dement (Amst) 2017;7:41-7. [PMID: 28239640 DOI: 10.1016/j.dadm.2017.01.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
299 Skrobot OA, O'brien J, Black S, Chen C, Decarli C, Erkinjuntti T, Ford GA, Kalaria RN, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I, Taragano F, Kril J, Cavalieri M, Jellinger K, Kovacs G, Engelborghs S, Lafosse C, Bertolucci P, Brucki S, Caramelli P, Toledo Ferraz Alves T, Bocti C, Fulop T, Hogan D, Hsiung G, Kirk A, Leach L, Robillard A, Sahlas D, Guo Q, Tian J, Hokkanen L, Jokinen H, Benisty S, Deramecourt V, Hauw J, Lenoir H, Tsatali M, Tsolaki M, Sundar U, Coen R, Korczyn A, Altieri M, Baldereschi M, Caltagirone C, Caravaglios G, Di Carlo A, Di Piero V, Gainotti G, Galluzzi S, Logroscino G, Mecocci P, Moretti D, Padovani A, Fukui T, Ihara M, Mizuno T, Kim S, Akinyemi R, Baiyewu O, Ogunniyi A, Szczudlik A, Bastos‐leite A, Firmino H, Massano J, Verdelho A, Kruglov L, Ikram M, Kandiah N, Arana E, Barroso‐ribal J, Calatayud T, Cruz‐jentoft A, López‐pousa S, Martinez‐lage P, Mataro M, Börjesson‐hanson A, Englund E, Laukka E, Qiu C, Viitanen M, Biessels G, Leeuw F, Heijer T, Exalto L, Kappelle L, Prins N, Richard E, Schmand B, Berg E, Flier W, Bilgic B, Allan L, Archer J, Attems J, Bayer A, Blackburn D, Brayne C, Bullock R, Connelly P, Farrant A, Fish M, Harkness K, Ince P, Langhorne P, Mann J, Matthews F, Mayer P, Pendlebury S, Perneczky R, Peters R, Smithard D, Stephan B, Swartz J, Todd S, Werring D, Wijayasiri S, Wilcock G, Zamboni G, Au R, Borson S, Bozoki A, Browndyke J, Corrada M, Crane P, Diniz B, Etcher L, Fillit H, Greenberg S, Grinberg L, Hurt S, Lamar M, Mielke M, Ott B, Perry G, Powers W, Ramos‐estebanez C, Reed B, Roberts R, Romero J, Saykin A, Seshadri S, Silbert L, Stern Y, Zarow C, Ben‐shlomo Y, Passmore AP, Love S, Kehoe PG. The Vascular Impairment of Cognition Classification Consensus Study. Alzheimer's & Dementia 2017;13:624-33. [DOI: 10.1016/j.jalz.2016.10.007] [Cited by in Crossref: 80] [Cited by in F6Publishing: 82] [Article Influence: 13.3] [Reference Citation Analysis]
300 Rogne S, Vangberg T, Eldevik P, Wikran G, Mathiesen EB, Schirmer H. Magnetic Resonance Volumetry: Prediction of Subjective Memory Complaints and Mild Cognitive Impairment, and Associations with Genetic and Cardiovascular Risk Factors. Dement Geriatr Cogn Dis Extra 2016;6:529-40. [PMID: 28101099 DOI: 10.1159/000450885] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
301 Chakraborty A, de Wit NM, van der Flier WM, de Vries HE. The blood brain barrier in Alzheimer's disease. Vascul Pharmacol 2017;89:12-8. [PMID: 27894893 DOI: 10.1016/j.vph.2016.11.008] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 9.7] [Reference Citation Analysis]
302 Merlini M, Shi Y, Keller S, Savarese G, Akhmedov A, Derungs R, Spescha RD, Kulic L, Nitsch RM, Lüscher TF, Camici GG. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease. Am J Physiol Heart Circ Physiol 2017;312:H232-8. [PMID: 27836896 DOI: 10.1152/ajpheart.00607.2016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
303 Weidung B, Littbrand H, Nordström P, Carlberg B, Gustafson Y. The association between SBP and mortality risk differs with level of cognitive function in very old individuals. J Hypertens 2016;34:745-52. [PMID: 26938812 DOI: 10.1097/HJH.0000000000000831] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
304 Lee JH, Francis PT, Ballard CG, Aarsland D, Kalaria RN, Wong PT, Chen CP, Lai MK. Muscarinic M1 Receptor Coupling to G-protein is Intact in Parkinson’s Disease Dementia. JPD 2016;6:733-9. [DOI: 10.3233/jpd-160932] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
305 Trusova NA, Levin OS, Arablinsky AV. [Clinical and neuropsychological features of Alzheimer's disease in the combination with cerebrovascular disease]. Zh Nevrol Psikhiatr Im S S Korsakova 2016;116:46-53. [PMID: 27723710 DOI: 10.17116/jnevro20161166246-53] [Reference Citation Analysis]
306 Iadecola C, Yaffe K, Biller J, Bratzke LC, Faraci FM, Gorelick PB, Gulati M, Kamel H, Knopman DS, Launer LJ, Saczynski JS, Seshadri S, Zeki Al Hazzouri A; American Heart Association Council on Hypertension; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Stroke Council. Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertension 2016;68:e67-94. [PMID: 27977393 DOI: 10.1161/HYP.0000000000000053] [Cited by in Crossref: 271] [Cited by in F6Publishing: 301] [Article Influence: 45.2] [Reference Citation Analysis]
307 Rosenthal LS, Salnikova YA, Pontone GM, Pantelyat A, Mills KA, Dorsey ER, Wang J, Wu SS, Mari Z. Changes in Verbal Fluency in Parkinson's Disease. Mov Disord Clin Pract 2017;4:84-9. [PMID: 30713950 DOI: 10.1002/mdc3.12421] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
308 Saito S, Ihara M. Interaction between cerebrovascular disease and Alzheimer pathology. Curr Opin Psychiatry 2016;29:168-73. [PMID: 26779861 DOI: 10.1097/YCO.0000000000000239] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
309 Keage HA, Smith A, Loetscher T, Psaltis P. Cognitive Outcomes of Cardiovascular Surgical Procedures in the Old: An Important but Neglected Area. Heart Lung Circ 2016;25:1148-53. [PMID: 27726955 DOI: 10.1016/j.hlc.2016.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
310 De Carolis A, Cipollini V, Donato N, Sepe-Monti M, Orzi F, Giubilei F. Cognitive profiles in degenerative dementia without evidence of small vessel pathology and small vessel vascular dementia. Neurol Sci 2017;38:101-7. [PMID: 27655157 DOI: 10.1007/s10072-016-2716-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
311 McAleese KE, Alafuzoff I, Charidimou A, De Reuck J, Grinberg LT, Hainsworth AH, Hortobagyi T, Ince P, Jellinger K, Gao J, Kalaria RN, Kovacs GG, Kövari E, Love S, Popovic M, Skrobot O, Taipa R, Thal DR, Werring D, Wharton SB, Attems J. Post-mortem assessment in vascular dementia: advances and aspirations. BMC Med 2016;14:129. [PMID: 27600683 DOI: 10.1186/s12916-016-0676-5] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 10.5] [Reference Citation Analysis]
312 De Strooper B, Karran E. The Cellular Phase of Alzheimer's Disease. Cell 2016;164:603-15. [PMID: 26871627 DOI: 10.1016/j.cell.2015.12.056] [Cited by in Crossref: 717] [Cited by in F6Publishing: 785] [Article Influence: 119.5] [Reference Citation Analysis]
313 Bhat NR. Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and Interventions. J Alzheimers Dis 2015;46:581-91. [PMID: 26402511 DOI: 10.3233/JAD-150098] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
314 Mudrova OA, Schekolova NB, Borikov FA. [The efficacy of divasa in the early recovery period of ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova 2016;116:48-54. [PMID: 27296802 DOI: 10.17116/jnevro20161163248-53] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
315 Ruthirakuhan MT, Herrmann N, Abraham EH, Lanctôt KL; Cochrane Dementia and Cognitive Improvement Group. Pharmacological interventions for apathy in Alzheimer's disease. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd012197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
316 Bertram S, Brixius K, Brinkmann C. Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer's disease in T2DM patients. Endocrine 2016;53:350-63. [PMID: 27160819 DOI: 10.1007/s12020-016-0976-8] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
317 Yamamoto Y, Nagakane Y, Tomii Y, Akiguchi I. High Morning and Bedtime Home Blood Pressures Strongly Predict for Post-Stroke Cognitive Impairment. J Stroke Cerebrovasc Dis 2016;25:1856-63. [PMID: 27156901 DOI: 10.1016/j.jstrokecerebrovasdis.2016.04.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
318 Kapasi A, Schneider J. Vascular contributions to cognitive impairment, clinical Alzheimer's disease, and dementia in older persons. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2016;1862:878-86. [DOI: 10.1016/j.bbadis.2015.12.023] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 13.0] [Reference Citation Analysis]
319 Love S, Miners JS. Cerebrovascular disease in ageing and Alzheimer's disease. Acta Neuropathol 2016;131:645-58. [PMID: 26711459 DOI: 10.1007/s00401-015-1522-0] [Cited by in Crossref: 146] [Cited by in F6Publishing: 136] [Article Influence: 24.3] [Reference Citation Analysis]
320 Reitz C. Toward precision medicine in Alzheimer's disease. Ann Transl Med 2016;4:107. [PMID: 27127760 DOI: 10.21037/atm.2016.03.05] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 8.3] [Reference Citation Analysis]
321 Hempel P, Heinig B, Jerosch C, Decius I, Karczewski P, Kassner U, Kunze R, Steinhagen-Thiessen E, Bimmler M. Immunoadsorption of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients With Mild to Moderate Dementia. Ther Apher Dial 2016;20:523-9. [PMID: 27096216 DOI: 10.1111/1744-9987.12415] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
322 Corriveau RA, Bosetti F, Emr M, Gladman JT, Koenig JI, Moy CS, Pahigiannis K, Waddy SP, Koroshetz W. The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline. Cell Mol Neurobiol 2016;36:281-8. [PMID: 27095366 DOI: 10.1007/s10571-016-0334-7] [Cited by in Crossref: 88] [Cited by in F6Publishing: 104] [Article Influence: 14.7] [Reference Citation Analysis]
323 Coca A, Monteagudo E, Doménech M, Camafort M, Sierra C. Can the Treatment of Hypertension in the Middle-Aged Prevent Dementia in the Elderly? High Blood Press Cardiovasc Prev 2016;23:97-104. [PMID: 27075454 DOI: 10.1007/s40292-016-0144-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
324 Ku H, Lee EK, Lee KU, Lee MY, Kwon JW. Higher prevalence of dementia in patients with schizophrenia: A nationwide population-based study. Asia Pac Psychiatry 2016;8:145-53. [PMID: 27028507 DOI: 10.1111/appy.12239] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
325 Zhong BL, Chen SL, Tu X, Conwell Y. Loneliness and Cognitive Function in Older Adults: Findings From the Chinese Longitudinal Healthy Longevity Survey. J Gerontol B Psychol Sci Soc Sci 2017;72:120-8. [PMID: 27013536 DOI: 10.1093/geronb/gbw037] [Cited by in Crossref: 89] [Cited by in F6Publishing: 108] [Article Influence: 14.8] [Reference Citation Analysis]
326 Gallart-Palau X, Lee BS, Adav SS, Qian J, Serra A, Park JE, Lai MK, Chen CP, Kalaria RN, Sze SK. Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease. Mol Brain 2016;9:27. [PMID: 26983404 DOI: 10.1186/s13041-016-0205-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 6.2] [Reference Citation Analysis]
327 Llorens F, Schmitz M, Ferrer I, Zerr I. CSF biomarkers in neurodegenerative and vascular dementias. Progress in Neurobiology 2016;138-140:36-53. [DOI: 10.1016/j.pneurobio.2016.03.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
328 Zamolodchikov D, Renné T, Strickland S. The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII. J Thromb Haemost 2016;14:995-1007. [PMID: 26613657 DOI: 10.1111/jth.13209] [Cited by in Crossref: 54] [Cited by in F6Publishing: 67] [Article Influence: 9.0] [Reference Citation Analysis]
329 Li JM, Cai Y, Liu F, Yang L, Hu X, Patrylo PR, Cai H, Luo XG, Xiao D, Yan XX. Experimental microembolism induces localized neuritic pathology in guinea pig cerebrum. Oncotarget 2015;6:10772-85. [PMID: 25871402 DOI: 10.18632/oncotarget.3599] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
330 Murphy MP, Corriveau RA, Wilcock DM. Vascular contributions to cognitive impairment and dementia (VCID). Biochim Biophys Acta 2016;1862:857-9. [PMID: 26921818 DOI: 10.1016/j.bbadis.2016.02.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
331 van Westen D, Lindqvist D, Blennow K, Minthon L, Nägga K, Stomrud E, Zetterberg H, Hansson O. Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET. Sci Rep 2016;6:20709. [PMID: 26856756 DOI: 10.1038/srep20709] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
332 Guerriero F, Ricevuti G. Extremely low frequency electromagnetic fields stimulation modulates autoimmunity and immune responses: a possible immuno-modulatory therapeutic effect in neurodegenerative diseases. Neural Regen Res 2016;11:1888-95. [PMID: 28197174 DOI: 10.4103/1673-5374.195277] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
333 Wilcock DM, Schmitt FA, Head E. Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome. Biochim Biophys Acta 2016;1862:909-14. [PMID: 26593849 DOI: 10.1016/j.bbadis.2015.11.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
334 Ishii M, Iadecola C. Adipocyte-derived factors in age-related dementia and their contribution to vascular and Alzheimer pathology. Biochim Biophys Acta 2016;1862:966-74. [PMID: 26546479 DOI: 10.1016/j.bbadis.2015.10.029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
335 Mohn TC, Koob AO. Adult Astrogenesis and the Etiology of Cortical Neurodegeneration. J Exp Neurosci 2015;9:25-34. [PMID: 26568684 DOI: 10.4137/JEN.S25520] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
336 Cai Z, Wang C, He W, Tu H, Tang Z, Xiao M, Yan LJ. Cerebral small vessel disease and Alzheimer's disease. Clin Interv Aging 2015;10:1695-704. [PMID: 26604717 DOI: 10.2147/CIA.S90871] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
337 Mancini S, Minniti S, Gregori M, Sancini G, Cagnotto A, Couraud PO, Ordóñez-Gutiérrez L, Wandosell F, Salmona M, Re F. The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease. Nanomedicine 2016;12:43-52. [PMID: 26410276 DOI: 10.1016/j.nano.2015.09.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
338 Mccaddon A, Miller JW. Assessing the association between homocysteine and cognition: reflections on Bradford Hill, meta-analyses, and causality. Nutr Rev 2015;73:723-35. [DOI: 10.1093/nutrit/nuv022] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
339 Oudin A, Forsberg B, Adolfsson AN, Lind N, Modig L, Nordin M, Nordin S, Adolfsson R, Nilsson LG. Traffic-Related Air Pollution and Dementia Incidence in Northern Sweden: A Longitudinal Study. Environ Health Perspect 2016;124:306-12. [PMID: 26305859 DOI: 10.1289/ehp.1408322] [Cited by in Crossref: 160] [Cited by in F6Publishing: 184] [Article Influence: 22.9] [Reference Citation Analysis]
340 Luo H, Han G, Wang J, Zeng F, Li Y, Shao S, Song F, Bai Z, Peng X, Wang YJ, Shi X, Lei H. Common Aging Signature in the Peripheral Blood of Vascular Dementia and Alzheimer's Disease. Mol Neurobiol 2016;53:3596-605. [PMID: 26099307 DOI: 10.1007/s12035-015-9288-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
341 Wu CY, Hu HY, Chow LH, Chou YJ, Huang N, Wang PN, Li CP. The Effects of Anti-Dementia and Nootropic Treatments on the Mortality of Patients with Dementia: A Population-Based Cohort Study in Taiwan. PLoS One 2015;10:e0130993. [PMID: 26098910 DOI: 10.1371/journal.pone.0130993] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
342 Qiu C, Fratiglioni L. A major role for cardiovascular burden in age-related cognitive decline. Nat Rev Cardiol 2015;12:267-77. [DOI: 10.1038/nrcardio.2014.223] [Cited by in Crossref: 178] [Cited by in F6Publishing: 192] [Article Influence: 25.4] [Reference Citation Analysis]
343 Jellinger KA. Pathogenesis and treatment of vascular cognitive impairment. Neurodegenerative Disease Management 2014;4:471-90. [DOI: 10.2217/nmt.14.37] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
344 O'Brien JT, Markus HS. Vascular risk factors and Alzheimer's disease. BMC Med 2014;12:218. [PMID: 25385509 DOI: 10.1186/s12916-014-0218-y] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 7.0] [Reference Citation Analysis]
345 Jellinger KA, Attems J. Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm 2015;122:505-21. [DOI: 10.1007/s00702-014-1288-x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 8.8] [Reference Citation Analysis]